0001178913-13-001514.txt : 20130517 0001178913-13-001514.hdr.sgml : 20130517 20130517084927 ACCESSION NUMBER: 0001178913-13-001514 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20130517 DATE AS OF CHANGE: 20130517 GROUP MEMBERS: AVI ZEEVI GROUP MEMBERS: HAREL BEIT-ON GROUP MEMBERS: VIOLA A.V. RRSAT LIMITED PARTNERSHIP GROUP MEMBERS: VIOLA P.E. GP LTD. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Dovrat Shlomo CENTRAL INDEX KEY: 0001314246 FILING VALUES: FORM TYPE: SC 13D MAIL ADDRESS: STREET 1: 16 ABBA EBAN AVENUE CITY: HERZELIYA STATE: L3 ZIP: 46725 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RRSat Global Communications Network Ltd. CENTRAL INDEX KEY: 0001375829 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-82408 FILM NUMBER: 13853276 BUSINESS ADDRESS: STREET 1: HANEGEV STREET CITY: AIRPORT CITY STATE: L3 ZIP: 70100 BUSINESS PHONE: 972-3-9280808 MAIL ADDRESS: STREET 1: HANEGEV STREET CITY: AIRPORT CITY STATE: L3 ZIP: 70100 SC 13D 1 zk1313130.htm SC 13D zk1313130.htm


 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
SCHEDULE 13D
[Rule 13d-101]
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
240.13d-2(a) AND AMENDMENTS THERETO FILED PURSUANT TO 240.13d-2(a)

 
RRSAT GLOBAL COMMUNICATIONS NETWORK LTD.
(Name of Issuer)
 

 
Ordinary Shares, par value NIS 0.01 per share
(Title of Class of Securities)
 
M8183P102
(CUSIP Number)

Harel Beit-On
Ackerstein Towers, Building D
12 Abba Eban Ave.
Hertzliya Pituach, 4672530, Israel
972-9-972-0500

 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

May 7, 2013

 (Date of Event Which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
 
 
 

 
 
CUSIP No. M8183P102
 
1.
NAMES OF REPORTING PERSONS
 
Viola A.V. RRsat, Limited Partnership
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)    
(a) o
(b) o
3. SEC Use Only
 
4.
SOURCE OF FUNDS (See Instructions)
 
WC
5.
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  
 
o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7.
SOLE VOTING POWER
 
0
8.
SHARED VOTING POWER
 
8,846,007 (1)
9.
SOLE DISPOSITIVE POWER
 
0
10.
SHARED DISPOSITIVE POWER
 
2,035,640 (1)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,846,007 (1)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
51.0% (2)
14.
TYPE OF REPORTING PERSON (See Instructions)
 
PN
 
 
(1)
See Item 5 for a description of the shares comprising this total share amount, and see Item 6 for a description of the arrangements pursuant to which voting or dispositive power (as appropriate) is shared with respect to these shares.
 
 
(2)
The percentage presented is based on 17,346,561 ordinary shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013).
 
 
2

 
 
CUSIP No. M8183P102
 
1.
NAMES OF REPORTING PERSONS
 
Viola P.E. GP Ltd.
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)    
(a) o
(b) o
3. SEC Use Only
 
4.
SOURCE OF FUNDS (See Instructions)
 
AF
5.
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  
 
o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7.
SOLE VOTING POWER
 
0
8.
SHARED VOTING POWER
 
8,846,007 (1)
9.
SOLE DISPOSITIVE POWER
 
0
10.
SHARED DISPOSITIVE POWER
 
2,035,640 (1)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,846,007 (1)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
51.0% (2)
14.
TYPE OF REPORTING PERSON (See Instructions)
 
CO
 
 
(1)
See Item 5 for a description of the shares comprising this total share amount, and see Item 6 for a description of the arrangements pursuant to which voting or dispositive power (as appropriate) is shared with respect to these shares.
 
 
(2)
The percentage presented is based on 17,346,561 ordinary shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013).
 
 
3

 
 
CUSIP No. M8183P102

1.
NAMES OF REPORTING PERSONS
 
Shlomo Dovrat
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)    
(a) o
(b) o
3. SEC Use Only
 
4.
SOURCE OF FUNDS (See Instructions)
 
OO
5.
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  
 
o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7.
SOLE VOTING POWER
 
0
8.
SHARED VOTING POWER
 
8,846,007 (1)
9.
SOLE DISPOSITIVE POWER
 
0
10.
SHARED DISPOSITIVE POWER
 
2,035,640 (1)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,846,007 (1)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
51.0% (2)
14.
TYPE OF REPORTING PERSON (See Instructions)
 
IN
 
 
(1)
See Item 5 for a description of the shares comprising this total share amount, and see Item 6 for a description of the arrangements pursuant to which voting or dispositive power (as appropriate) is shared with respect to these shares.
 
 
(2)
The percentage presented is based on 17,346,561 ordinary shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013).
 
 
4

 
 
CUSIP No. M8183P102
 
1.
NAMES OF REPORTING PERSONS
 
Harel Beit-On
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)    
(a) o
(b) o
3. SEC Use Only
 
4.
SOURCE OF FUNDS (See Instructions)
 
OO
5.
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  
 
o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7.
SOLE VOTING POWER
 
0
8.
SHARED VOTING POWER
 
8,846,007 (1)
9.
SOLE DISPOSITIVE POWER
 
0
10.
SHARED DISPOSITIVE POWER
 
2,035,640 (1)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,846,007 (1)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
51.0% (2)
14.
TYPE OF REPORTING PERSON (See Instructions)
 
IN
 
 
(1)
See Item 5 for a description of the shares comprising this total share amount, and see Item 6 for a description of the arrangements pursuant to which voting or dispositive power (as appropriate) is shared with respect to these shares.
 
 
(2)
The percentage presented is based on 17,346,561 ordinary shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013).
 
 
5

 
 
 
CUSIP No. M8183P102
 
1.
NAMES OF REPORTING PERSONS
 
Avi Zeevi
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(See Instructions)    
(a) o
(b) o
3. SEC Use Only
 
4.
SOURCE OF FUNDS (See Instructions)
 
OO
5.
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  
 
o
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Israel
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7.
SOLE VOTING POWER
 
0
8.
SHARED VOTING POWER
 
8,846,007 (1)
9.
SOLE DISPOSITIVE POWER
 
0
10.
SHARED DISPOSITIVE POWER
 
2,035,640 (1)
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
8,846,007 (1)
12.
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
o
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
51.0% (2)
14.
TYPE OF REPORTING PERSON (See Instructions)
 
IN
 
 
(1)
See Item 5 for a description of the shares comprising this total share amount, and see Item 6 for a description of the arrangements pursuant to which voting or dispositive power (as appropriate) is shared with respect to these shares.
 
 
(2)
The percentage presented is based on 17,346,561 ordinary shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013).
 
 
6

 

Item 1.  Security and Issuer.
 
This statement of beneficial ownership on Schedule 13D (this “Statement”) relates to the Ordinary Shares, par value 0.01 New Israeli Shekels (“NIS”) per share (the “Ordinary Shares”), of RRsat Global Communications Network Ltd., an Israeli company (the “Issuer” or “RRsat”). The principal executive office of RRsat is located at RRsat Building, Hanegev Street, POB 1056, Airport City 70100, Israel.

This Statement is being filed by the Reporting Persons (as defined in Item 2 below) to report their having acquired beneficial ownership of in excess of 5% of the issued and outstanding Ordinary Shares of the Issuer. This acquisition of beneficial ownership occurred as a result of the closing, on May 7, 2013, of the purchase by Viola A.V. RRsat (as defined in Item 2 below) of 1,214,259 Ordinary Shares from Mr. David Rivel (“Rivel”) pursuant to a share purchase agreement, dated as of April 4, 2013, by and between Rivel and Viola A.V. RRsat (the “Rivel SPA”).  In connection with the foregoing closing, the Reporting Persons have also gained voting and dispositive rights over additional Ordinary Shares and Viola A.V. RRsat has subjected the Ordinary Shares beneficially owned by the Reporting Persons to voting and dispositive rights of other shareholders of the Issuer, in each case under separate shareholders agreements entered into by Viola A.V. RRsat with Rivel, and with Del-Ta Engineering Equipment Ltd. (“Del-Ta Engineering”), respectively.  See Item 6 below for a description of these arrangements.

Item 2.  Identity and Background.
 
This Statement is being filed by each of: (i) Viola A.V. RRsat, Limited Partnership, an Israeli limited partnership (“Viola A.V. RRsat”), (ii) Viola P.E. GP Ltd., an Israeli limited liability company (“Viola P.E. GP”), which serves as the managing general partner of Viola A.V. RRsat (together with Viola A.V. RRsat, collectively, the “Reporting Entities”); (iii) Shlomo Dovrat, (iv) Harel Beit-On and (v) Avi Zeevi (each such natural person, a “Reporting Individual,” and, together with the Reporting Entities, collectively, the “Reporting Persons”).

Viola A.V. RRsat, an Israeli limited partnership, directly holds the Ordinary Shares reported in this Statement.  Viola P.E. GP, an Israeli limited liability company, serves as the general partner of Viola A.V. RRsat and possesses voting and investment authority with respect to the Ordinary Shares held thereby.  Mr. Harel Beit-On is the sole director of Viola P.E. GP.  The holdings of equity interests of Viola P.E. GP by Messrs. Shlomo Dovrat, Harel Beit-On and Avi Zeevi constitute, directly or indirectly, a majority of the issued and outstanding share capital of Viola P.E. GP., in the aggregate, and provide them with ultimate voting and investment authority with respect to the Ordinary Shares directly held by Viola A.V. RRsat.

The following identity and background information is presented with respect to each of the Reporting Entities:

(a)           State of Organization: Each of Viola A.V. RRsat and Viola P.E. GP – Israel.

(b)           Principal Business: Viola A.V. RRsat is a holding entity that was organized for the purpose of acquiring and holding Ordinary Shares of the Issuer.  Viola P.E. GP is a company serving as the managing general partner.

(c)           Address of Principal Business and Principal Office: 12 Abba Eban Avenue, Herzliya Pituach 4672530, Israel.

(d)           Criminal Proceedings:  During the last five years, neither of the Reporting Entities has been convicted in any criminal proceeding.

(e)           Civil Proceedings Involving Securities Law Violations:  During the last five years, neither of the Reporting Entities has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which it is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
 
7

 

The following identity and background information is presented with respect to each of the Reporting Individuals:

(b)           Business Address: 12 Abba Eban Avenue, Herzliya Pituach 4672530, Israel.

(c)           Present Principal Occupation: Business person.

(d)           Criminal Proceedings:  During the last five years, none of the Reporting Individuals has been convicted in any criminal proceeding.

(e)           Civil Proceedings Involving Securities Law Violations:  During the last five years, none of the Reporting Individuals has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction, as a result of which he is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f)           Citizenship: Israel

Item 3.  Source and Amount of Funds or Other Consideration.
 
A cash amount of $10,106,950 was paid by Viola A.V. RRsat for the acquisition of the 1,214,259 Ordinary Shares from Rivel upon the closing under the Rivel SPA.  Such cash consideration was funded from the working capital of Viola A.V. RRsat, via convertible loans from its limited partners.

The acquisition of beneficial ownership of additional Ordinary Shares by the Reporting Persons by virtue of the arrangements under the shareholders agreements with Rivel and Del-Ta Engineering, respectively, did not require the payment of cash consideration.  Instead the agreements, representations and covenants of Viola A.V. RRsat under those shareholders agreements, served as the consideration whereby the Reporting Persons have acquired beneficial ownership over additional Ordinary Shares held by Rivel and Del-Ta Engineering,

Item 4. Purpose of Transaction.
 
The Reporting Persons have acquired Ordinary Shares of RRsat for investment purposes. Besides their current ownership of Ordinary Shares, the Reporting Persons also expect to acquire an additional 2,255,053 Ordinary Shares (subject to adjustment) from Kardan Communications Ltd. pursuant to the Kardan SPA (as defined in Item 6 below), assuming that all closing conditions thereto are met, including receipt of required regulatory approvals. The Reporting Persons intend to continue to review their investment in RRsat and may, based on such review as well as other factors (including, among other things, their evaluation of RRsat’s business, prospects and financial condition, amounts and prices of available Ordinary Shares of RRsat, the market for RRsat’s securities, other opportunities available to the Reporting Persons and general market and economic conditions), acquire additional Ordinary Shares of RRsat or sell Ordinary Shares of RRsat, on the open market or in privately negotiated transactions. The Reporting Persons reserve the right at any time to change their present intention with respect to any or all of the matters referred to in this Item 4, or to dispose of any or all of the Ordinary Shares of RRsat acquired by them (subject to any applicable requirement to update this Statement as a result of any such changed intent or disposition of Ordinary Shares under the rules of the U.S. Securities and Exchange Commission).

Except as set forth herein, as of the filing of this Statement, the Reporting Persons do not have any definitive plans or proposals which relate to or would result in any of the following: (a) the acquisition by the Reporting Persons of additional Ordinary Shares (other than under the Kardan SPA), or the disposition of Ordinary Shares that they hold; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) a material change in the present capitalization or dividend policy of the Issuer; (e) any other material change in the Issuer’s business or corporate structure; (f) changes in the Issuer’s articles of association (except for board nomination provisions, as contemplated under the Del-Ta- Viola Shareholders Agreement, as described in Item 6 below) or other actions which may impede the acquisition of control of the Issuer by any other person; (g) causing the Ordinary Shares to be delisted from a national securities exchange (such as the NASDAQ Global Select Market, on which the Ordinary Shares are currently listed) or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (h) causing the Ordinary Shares to become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (j) any action similar to any of those enumerated above.
 
 
8

 

Item 5.  Interest in Securities of the Issuer.
 
All calculations of beneficial ownership percentage in this Statement are made on the basis of 17,346,561 Ordinary Shares of the Issuer outstanding as of February 28, 2013 (as reported by the Issuer in its annual report on Form 20-F for the year ended December 31, 2012, filed with the SEC on March 11, 2013)

(a)           Each of the Reporting Persons may be deemed to beneficially own 8,846,007 Ordinary Shares of the Issuer, representing approximately 51.0% of the issued and outstanding share capital of the Issuer.  These 8,846,007 Ordinary Shares consist of the following:

(i) 1,214,259 Ordinary Shares held by Viola A.V. RRsat, as to which:

(v)     the remaining Reporting Persons may be deemed to share voting power due to their possession of direct (in the case of Viola P.E. GP) or indirect (in the case of the Reporting Individuals) authority to make voting decisions with respect thereto;

(w)     Del-Ta Engineering may be deemed to share voting power, due to the board designation provisions to which such Ordinary Shares are subject in favor of Del-Ta Engineering under the Del-Ta-Viola Shareholders Agreement (as defined and described in Item 6 below);

(x)      Rivel may be deemed to share voting power, due to the obligation of Viola A.V. RRsat under the Rivel-Viola Shareholders Agreement (as defined and described in Item 6 below) to vote an unspecified portion of such 1,214,259  Ordinary Shares in favor of the appointment of Rivel, personally, as a director of RRsat;

(y)      the remaining Reporting Persons may be deemed to share dispositive power with Viola A.V. RRsat due to their possession of direct (in the case of Viola P.E. GP) or indirect (in the case of the Reporting Individuals) authority to make investment decisions with respect thereto; and

(z)       Rivel may be deemed to share dispositive power, due to:

 
(A)
the conditional call option granted by Viola A.V. RRsat to Rivel to repurchase all of such 1,214,259 Ordinary Shares from Viola A.V. RRsat under the Rivel-Viola Shareholders Agreement (as described in Item 6 below); and

 
(B)
the tag-along rights granted by Viola A.V. RRsat to Rivel under the Rivel-Viola Shareholders Agreement in the event of a transfer of such 1,214,259 Ordinary Shares by Viola A.V. RRsat;

 (ii) 821,381 Ordinary Shares held by Rivel, as to which:

(w) Viola A.V. RRsat may be deemed to share voting power, due to the agreement by Rivel under the Rivel-Viola Shareholders Agreement to vote all Ordinary Shares held by it as directed by Viola A.V. RRsat, and due to the related proxy delivered by Rivel to Violas A.V. RRsat in respect of such 821, 381 Ordinary Shares in furtherance of such voting agreement; and
 
 
9

 

(x)      the remaining Reporting Persons may be deemed to share voting power, due to their possession of direct (in the case of Viola P.E. GP) or indirect (in the case of the Reporting Individuals) authority to make voting decisions on behalf of Viola A.V. RRsat with respect to Ordinary Shares for which Viola A.V. RRsat possesses voting rights (such as the subject 821,381 Ordinary Shares);

(y)     Viola A.V. RRsat may be may deemed to share dispositive power, due to the right of first offer and tag-along rights granted by Rivel to Viola A.V. RRsat under the Rivel-Viola Shareholders Agreement with respect to those 821,381 Ordinary Shares; and

(z)       the remaining Reporting Persons may be deemed to share dispositive power, due to their possession of direct (in the case of Viola P.E. GP) or indirect (in the case of the Reporting Individuals) authority to make investment decisions on behalf of Viola A.V. RRsat with respect to Ordinary Shares for which Viola A.V. RRsat possesses dispositive rights (such as the subject 821,381 Ordinary Shares);

(iii)  6,810,367 Ordinary Shares held by Del-Ta Engineering, as to which:
 
(x)      Viola A.V. RRsat may be deemed to share voting power, due to the board designation provisions to which such Ordinary Shares are subject in favor of Viola A.V. RRsat under the Del-Ta-Viola Shareholders Agreement (as described in Item 6 below); and

(y)      the remaining Reporting Persons may be deemed to share voting power, due to their possession of direct (in the case of Viola P.E. GP) or indirect (in the case of the Reporting Individuals) authority to make voting decisions on behalf of Viola A.V. RRsat with respect to Ordinary Shares for which Viola A.V. RRsat possesses voting rights (such as the subject 6,810,367 Ordinary Shares);

Each of the Reporting Persons disclaims beneficial ownership of all Ordinary Shares as to which beneficial ownership may be attributed to him, her or it, as appropriate, except to the extent of his, her or its pecuniary interest therein and except, in the case of Viola A.V. RRsat, for the 1,214,259 Ordinary Shares held directly by Viola A.V. RRsat.

Except for the foregoing, the Reporting Persons do not possess any beneficial ownership in any of the Issuer’s Ordinary Shares described in this Statement.

(b)           The Reporting Persons possess shared power to vote and direct the vote, and shared power to dispose or to direct the disposition of, the Issuer’s Ordinary Shares as described in paragraph (a) of this Item 5 above.

(c)           Except for the transactions described in Item 1 of this Statement, none of the Reporting Persons has effected any transactions in securities of the Issuer in the past 60 days.

(d)           The various limited partners of Viola A.V. RRsat have the right to receive dividends from, and proceeds from the sale of, the 1,214,259 Ordinary Shares held by Viola A.V. RRsat.

(e)           Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
Del-Ta- Viola Shareholders AgreementOn April 17, 2013, Viola A.V. RRsat and Del-Ta Engineering entered into a shareholders agreement (the “Del-Ta- Viola Shareholders Agreement”) relating to their holdings in RRsat.  The agreement was entered into in connection with the proposed purchase of Ordinary Shares by Viola A.V. RRsat pursuant to the Rivel SPA and pursuant to that certain share purchase agreement, dated April 4, 2013, by and between Viola A.V. RRsat and Kardan Communications Ltd. (“Kardan Communications”) (the “Kardan SPA”).  The key terms of the Del-Ta- Viola Shareholders Agreement are as follows:
 
 
10

 
 
RRat Shareholders Meeting - Each of the parties agreed to cause RRsat to call a general meeting of shareholders as soon as possible after the consummation of the sale of Ordinary Shares by Kardan Communications to Viola A.V. RRsat pursuant to the Kardan SPA (the “Kardan Closing”) (which has not occurred yet as of the filing of this Statement) and not more than 45 days thereafter, for the purpose of:
 
·          
amending RRsat’s Articles of Association (i) to increase the size of RRsat’s board of directors and provide that members of RRsat’s board of directors shall be elected, replaced and removed by a simple majority vote and (ii) to require a threshold quorum of 70% of RRsat’s directors and a supermajority of more than 70% of the voting directors for approving the following specified matters:

 
material changes to RRsat’s business;
 
 
the issuance of RRsat securities constituting more than 25% of RRsat’s outstanding share capital (on a fully diluted basis) in the aggregate within any period of 24 months;

 
the appointment, removal and compensation of RRsat’s chief executive officer;
 
 
an acquisition or investment by RRsat in excess of $30 million; and
 
 
a change to RRsat’s dividend policy or the declaration of a dividend inconsistent with the dividend policy then in effect;
 
·          
replacing all RRsat directors in accordance with the nominee designation process agreed between Del-Ta and Viola A.V. RRsat, as described below (other than the two external directors under the Israeli Companies Law, 5759-1999 (the “Companies Law”), and a third unaffiliated director).
 
RRsat Board Designation – The parties agreed that each shareholder shall designate four directors to RRsat’s board of directors and one outside director, and jointly agree on the identity of a third unaffiliated director, and vote their Ordinary Shares (including Ordinary Shares for which each party holds voting power) in favor of such designated nominees. The right of a shareholder to designate directors shall be reduced from four directors to two directors if such shareholder holds voting power for less than 3,469,312 Ordinary Shares and more than 1,734,656 Ordinary Shares.  In addition, the parties agreed that effective upon the consummation of the sale of Ordinary Shares by Rivel to Viola A.V. RRsat pursuant to the Rivel SPA (the “Rivel Closing”) (which occurred on May 7, 2013), the parties shall take all action necessary to ensure that at least one designee of Viola A.V. RRsat is appointed a director of RRsat.
 
Appointment of Chairman – The parties agreed that the Chairman of RRsat’s board of directors will be elected out of the designated directors of the party holding a greater portion of RRsat's voting power, which party shall initially be Del-Ta Engineering.  Viola A.V. RRsat shall obtain such appointment right if its voting power in RRsat exceeds Del-Ta Engineering’s voting power by at least 4%.
 
Dividend Policy – The parties agreed that, subject to the discretion of RRsat’s board of directors from time to time and to the extent permitted by applicable law, RRsat shall distribute to its shareholders, after the end of each calendar quarter, 50% of the net profit recorded in RRsat’s quarterly financial statements.
 
 Allocation of Sales under Rule 144 and Registration Rights – The parties agreed on a mechanism for allocating the number of Ordinary Shares permitted to be sold under the safe harbor of Rule 144 under the Securities Act of 1933, as amended, and that the currently-effective Registration Statement on Form F-3 of RRsat shall be supplemented to include Viola A.V. RRsat as a selling shareholder, including in any new registration statement replacing the currently-effective Registration Statement on Form F-3.
 
 
11

 
 
Participation in Purchases – Each party shall have the right to participate in 50% of any future purchase of Ordinary Shares by the other party, other than purchases (i) in connection with the Kardan SPA and Rivel SPA (including any option rights thereunder or pursuant to exercise of its rights under the shareholders agreements with Rivel and Kardan Communications), (ii) purchases from specified permitted transferees or (iii) limited purchases of Ordinary Shares on the market of up to 4% of RRsat's issued and outstanding capital in the aggregate within any period of 12 months.

Term and Termination – Each party may terminate the agreement when the other party holds less than 10% of the voting power of RRsat.
 
Waiver of Rights – Del-Ta Engineering agreed (i) to waive any right it may have (A) to purchase the Ordinary Shares proposed to be sold by Rivel to Viola A.V. RRsat pursuant to the Rivel SPA so long as the Rivel SPA is not terminated, and (B) to tag -long to the proposed sale by Kardan Communications to Viola A.V. RRsat pursuant to the Kardan SPA so long as the Kardan SPA is not terminated; and (ii) that the Del-Ta- Rivel Shareholders Agreement (as defined below) shall have no force and effect upon the Rivel Closing.

Rivel- Viola Shareholders AgreementOn April 4, 2013, Viola A.V. RRsat and Rivel entered into a Shareholders Agreement (the “Rivel-Viola Shareholders Agreement”) relating to their holdings in RRsat.  The Rivel-Viola Shareholders Agreement was entered into in connection with the proposed purchase of Ordinary Shares by Viola A.V. RRsat pursuant to the Rivel SPA.  The key terms of the Rivel-Viola Shareholders Agreement are as follows:
  
Voting Undertaking 
(i) At any annual, extraordinary, or special meeting of the shareholders of RRsat and at any postponement(s) or adjournment(s) thereof, or pursuant to any consent in lieu of a meeting or otherwise, Rivel shall vote (or cause to be voted) all of the Ordinary Shares of RRsat, now or hereafter beneficially owned by Rivel and its affiliates (the “Shares”), as directed by Viola A.V. RRsat, for as long as Viola A.V. RRsat and its affiliates beneficially own at least 5% of RRsat’s issued and outstanding share capital. In addition, Rivel delivered to Viola A.V. RRsat an irrevocable proxy, to vote the Shares at any meeting of the shareholders of RRsat, or pursuant to any consent in lieu of a meeting or otherwise.

(ii) At each general meeting of shareholders in which members of the Board of Directors of RRsat are elected (other than election of external directors under the Companies Law), Viola A.V. RRsat shall vote  a portion of the Shares, in favor of the appointment of Rivel, personally, as a director of RRsat with the good faith intention that Rivel shall indeed be elected as a director in such vote, provided that in such vote at least 3 directors are elected by Viola A.V. RRsat to the Board of Directors of RRsat and provided that Rivel qualifies with all applicable legal requirements. The foregoing provisions shall be in effect only for as long as Rivel and his affiliates hold, as of such date, the same number of Shares as held by them on the date of Rivel-Viola Shareholders Agreement, except for shares sold under the Rivel SPA.
 
Standstill  – Rivel shall not, and shall cause his affiliates not to, directly or indirectly, (i) for a period of two years from the closing under the Kardan SPA, but not later than 27 months after May 6, 2013, offer for sale (including short sale), sell, transfer, exchange, tender, create any Encumbrance, assign, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise dispose of, or enter into any contract or arrangement with respect to, or consent to, or offer, any of the foregoing with respect to, any Shares or any interest therein, to any person; (ii) as long as the Rivel-Viola Shareholders Agreement is not terminated in accordance with its terms, except as contemplated by or permitted by such agreement, grant any proxies or powers of attorney, deposit any Shares into a voting trust or enter into a voting agreement, in each case with respect to any Shares; and (iii) as long as the Rivel-Viola Shareholders Agreement is not terminated in accordance with its terms, subject any Shares to any shareholders agreement, or other agreement or understandings relating to any attribute thereof.
 
Right of First Offer – If Rivel and/or any of his respective affiliates which are or become the beneficial owners of any Shares wishes to sell or otherwise transfer, directly or indirectly, any Shares, then he shall be required to first offer the offered Shares to Viola A.V. RRsat, which shall have 14 business days, or three (3) business days in case of a sale in accordance with Rule 144 under the Securities Act of 1933, to notify Rival that it wishes to purchase the offered Shares. If Viola A.V. RRsat does not notify that it wishes to purchase the offered Shares, Rivel and/or any of his respective affiliates shall be entitled to consummate the sale to a third party within a 90-day period, on terms that are not more favorable than those proposed to Viola A.V. RRsat.
 
 
12

 
 
 Allocation of Sales under Rule 144 – The parties agreed on a mechanism for allocating the amount of Ordinary Shares permitted to be sold under the safe harbor of Rule 144 under the Securities Act of 1933, as amended.
 
Tag-Along- If either party or any of its affiliates which are or become the beneficial owners of any Shares, wishes to sell of otherwise transfer any Shares to a proposed third party purchaser, other than in a sale in accordance with Rule 144 under the Securities Act of 1933, and if, to the extent applicable, Viola A.V. RRsat did not exercise its foregoing Right of First Offer, then it shall send to each other shareholder that holds at least 2% of the issued and outstanding share capital of RRsat at such time (an “Eligible Shareholder”) a written notice, which will specify the terms of such proposed transaction. Each Eligible Shareholder shall have the right to notify the selling party in writing, within 7 business days after it is informed of the tag-along offer, of its decision to exercise its tag along right, in an amount of Ordinary Shares of up to the Eligible Shareholder’s pro-rata portion.
 
Call Option - Viola A.V. RRsat has granted Rivel a call option to purchase the shares sold by Rivel to Viola A.V. RRsat under the Rivel SPA. The Call Option may be exercised by Rivel during the period commencing on the termination of the Kardan SPA (if any) and ending on the date that is 30 days thereafter

Term and Termination- Each of Viola A.V. RRsat and Rivel may terminate the Rivel-Viola Shareholders Agreement by written notice to the other party on any date on which Viola A.V. RRsat holds in the aggregate less than (i) 5% of RRsat’s issued and outstanding share capital, or (ii) if the purchase of shares by Viola A.V. RRsat from Kardan under the Kardan SPA is consummated, 10% of RRsat’s issued and outstanding share capital. In addition, Viola A.V. RRsat may terminate the Rivel-Viola Shareholders Agreement by written notice to Rivel commencing on the first date on which Rivel holds in the aggregate less than 2.5% of RRsat’s issued and outstanding share capital. The Rivel-Viola Shareholders Agreement shall also automatically terminate upon the consummation of a liquidation event in RRsat.
 
Item 7. Material to be Filed as Exhibits.
 
Exhibit 1 – Share Purchase Agreement, dated April 4, 2013, by and between Rivel and Viola P.E. GP, as a nominee, on behalf of Viola A.V. RRsat.

Exhibit 2 --  Shareholders Agreement, dated as of April 4, 2013, by and between Viola P.E. GP, as nominee on behalf of Viola A.V. RRsat,  and Rivel.
 
Exhibit 3 -- Shareholders Agreement, dated as of April 17, 2013, by and between (i) Viola P.E. GP, as nominee on behalf of Viola A.V. RRsat, and (ii) Del-Ta Engineering (incorporated by reference to Exhibit 6 to the Statement of Beneficial Ownership on Schedule 13D filed by InterGamma International Trade Founded by InterGamma Investments Co., Del-Ta Engineering, Rapac Communication & Infrastructure Ltd., Inter-Gamma Investment Company Ltd. and Tanhum Oren with the Securities and Exchange Commission on April 29, 2013) (SEC File No. 005-82408)

Exhibit 4 -- Share Purchase Agreement, dated April 4, 2013, by and between Viola P.E. GP, as nominee on behalf of Viola A.V. RRsat, and Kardan Communications.
 
Exhibit 5 -- Joint Filing Agreement pursuant to Rule 13d-1(k)(1)
 
 
13

 
 
SIGNATURE
 
After reasonable inquiry and to the best of the knowledge and belief of the undersigned, we certify that the information set forth in this statement is true, complete and correct.
 
  Viola A.V. RRsat, Limited Partnership

By:  Viola P.E. GP Ltd.
Its general partner

By: /s/ Harel Beit-On
Name: Harel Beit-On

By: /s/ Avi Zeevi
Name: Avi Zeevi
 
Viola P.E. GP Ltd.
By: /s/ Harel Beit-On
Name: Harel Beit-On

By: /s/ Avi Zeevi
Name: Avi Zeevi
 
/s/ Shlomo Dovrat
Shlomo Dovrat

/s/ Harel Beit-On
Harel Beit-On

/s/ Avi Zeevi
Avi Zeevi
 
Dated: May 17, 2013
 
 
14


EX-1 2 exhibit_1.htm EXHIBIT 1 exhibit_1.htm


Exhibit 1
SHARE PURCHASE AGREEMENT
 
This Share Purchase Agreement (the “Agreement”) is entered into on this 4th day of April, 2013 by and among Mr. David Rivel (“Seller”) and Viola P.E. GP Ltd., an Israeli company (the “Purchaser”).

WITNESSETH:

WHEREAS, Seller is the sole owner, beneficial and of record, of 2,035,640 Ordinary Shares, par value NIS 0.01 each, of RRSAT GLOBAL COMMUNICATIONS NETWORK LTD., a company incorporated under the laws of the State of Israel (the “Ordinary Shares” and the “Company”, respectively);

WHEREAS, the Seller wishes to sell, transfer and assign to the Purchaser, and the Purchaser wishes to purchase, assume and receive from Seller, the Purchased Shares (as defined below) for the consideration set forth herein, subject to the terms and conditions set forth in this Agreement; and

WHEREAS, concurrently with the execution of this Agreement, (i) the Purchaser is entering into that certain Share Purchase Agreement, providing for the purchase by the Purchaser of Ordinary Shares from Kardan Communications Ltd.; and (ii) the Purchaser and the Seller are entering into that certain Shareholders Agreement in the form attached hereto as Exhibit A (the “Shareholders Agreement”).

NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements contained herein, the parties hereto, intending to be legally bound, agree as follows:
 
1.
Purchase and Sale of the Purchased Shares.
 
1.1.           At the Closing (as defined below) and subject to the terms and conditions of this Agreement, the Seller shall sell, convey, transfer, assign and deliver to the Purchaser, and the Purchaser shall, in reliance on the representations and warranties of the Seller contained herein, purchase and acquire from the Seller, 1,214,259 Ordinary Shares (as may be adjusted in accordance with Section 1.4 below) (the “Purchased Shares”), free and clear of any Encumbrances, in consideration for a gross aggregate purchase price for all Purchased Share of $10,106,950. (as may be adjusted in accordance with Section 1.4 below) (the “Purchase Price”). At the Closing, the Purchaser shall purchase and the Seller shall sell all (and not part of the) Purchased Shares.
 
1.2.           All taxes due as a result of the sale and purchase of the Purchased Shares hereunder shall be the sole liability of the Seller. Unless the Seller provides to the Purchaser a valid certificate from the Israeli Tax Authorities providing full exemption from withholding tax (or a lower rate of withholding) or a tax determination from the Israeli Tax Authorities indicating otherwise, at least 2 business days in advance of the Closing Date, then the Purchaser shall be entitled to deduct and withhold from such payment such amount as required to be deducted and withheld under any applicable law. To the extent that amounts are so withheld, such withheld amounts shall be treated for all purposes of this Agreement as having been delivered and paid to the Seller in respect of which such deduction and withholding was made.
 
1.3.           In the event of any stock split (bonus shares), consolidation, share dividend (including any dividend or distribution of securities convertible into share capital), reorganization, reclassification, combination, recapitalization or other like change with respect to the Purchased Shares occurring after the date hereof and prior to the Closing, all references in this Agreement to specified price per share, numbers of shares and all calculations provided for that are based upon numbers affected thereby, shall be equitably adjusted to the extent necessary to provide the parties the same economic effect as contemplated by this Agreement prior to such event.
 
 
 

 
 
1.4.           The parties shall verify with the Company immediately prior to the Closing that the number of Ordinary Shares stated above to be Purchased Shares constitute 7% of the issued and outstanding share capital of the Company, and to the extent that based on such verification the number of Purchased Shares constitutes less than 6.7%, then Purchaser shall have the option to either (i) proceed with the Closing, (ii) require Seller to increase the number of Purchased Shares to up to 6.7% of the issued and outstanding share capital of the Company, provided that the Purchase Price shall be increased by $8.324 per share, or (iii) terminate the Agreement.
 
2.
Closing.
 
2.1.           Unless this Agreement is earlier terminated pursuant to Sections 1.4 or 7 hereof, the consummation of the sale and purchase of the Purchased Shares (the “Closing”) will take place at the offices of Meitar Liquornik Geva Leshem Tal, Law Offices, 16 Abba Hillel Road, Ramat Gan, Israel, at a date to be determined by Purchaser which is no later than ten (10) Business Days following the satisfaction or waiver of the closing condition set forth herein (other than those that by their terms are to be satisfied or waived at the Closing, but subject to the satisfaction or waiver of those conditions), or at such other time, date and location as the Purchaser and Seller shall agree in writing. The date upon which the Closing hereunder actually occurs shall be referred to herein as the “Closing Date”. All actions at the Closing and all transactions occurring at the Closing shall be deemed to take place simultaneously and no transactions shall be deemed to have been completed or any document delivered until all such transactions have been completed and all required documents delivered.
 
2.2.           At the Closing, the Seller shall deliver, or cause to be delivered, to the Purchaser the following documents:
 
2.2.1.                Share transfer deed, duly executed by the Seller, transferring to the Purchaser the Purchased Shares, in the form attached hereto as Exhibit 2.2.1;
 
2.2.2.                If the Purchased Shares are evidenced by a certificate in the name of the Seller, original share certificate(s) representing the Purchased Shares held by the Seller (or an affidavit of loss in lieu thereof);
 
2.2.3.                If the Purchased Shares are held electronically, a written confirmation from Seller’s broker and/or custodian that the Purchased Shares have been delivered, in electronic format, to and credit towards Purchaser's account at its broker and/or custodian;
 
2.2.4.                If the Purchased Shares are evidenced by a certificate in the name of the Seller, an irrevocable letter of instruction from the Company instructing the transfer agent of the Company's Ordinary Shares to record the transfer pursuant to this Agreement, substantially in the form attached hereto as Exhibit 2.2.4; and
 
2.2.5.                A certificate in the form attached hereto as Exhibit 2.2.5 executed by the Seller certifying that: (i) the representations and warranties of the Seller hereunder are true and correct as of the date hereof and as of the Closing Date as if made on such date; (ii) all covenants required by the terms hereof to be performed by the Seller on or prior to the Closing Date have been so performed; and (iii) the number of Purchased Shares if adjusted pursuant to Section 1.4.
 
2.3.           At the Closing the Purchase Price shall be deposited by Purchaser with MLG&LB Trust Company Ltd., as escrow agent, and shall be released to Seller upon either receipt of a share certificate representing the Purchased Shares in the name of the Purchaser or receipt of written confirmation from Purchaser’s broker or custodian that the Purchased Shares, in electronic format, are held by it. Purchaser’s deposit of the purchase price pursuant to this Section shall satisfy Purchaser’s obligation to make payment pursuant to this Agreement.
 
 
- 2 -

 
 
3.             Representations and Warranties of Seller. The Seller hereby represents and warrants to the Purchaser as follows:
 
3.1.           Seller has the full legal capacity, power and authority to execute and deliver this Agreement and any agreement, document and instrument provided for or contemplated herein with respect to the Purchased Shares (collectively, the “Transaction Documents”) and to perform the transaction contemplated hereby and thereby. The execution, delivery and performance by the Seller of each of the Transaction Documents has been duly executed and delivered by Seller. The Transaction Documents constitute or will, when executed and delivered by all parties thereto, constitute Seller’s valid and legally binding obligation enforceable against him in accordance with its respective terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.
 
3.2.           The Seller has good and valid title to, and is the sole lawful owner, beneficially and of record, of all of the Purchased Shares.  The Seller has sole voting power and sole power to issue instructions with respect to the matters set forth in this Agreement, sole power of disposition and sole power to agree to all of the matters set forth in this Agreement. The Purchased Shares are a capital asset of the Seller. At the Closing, the Seller shall convey to the Purchaser, and the Purchaser shall acquire, good and marketable title to the Purchased Shares, free and clear of any and all Encumbrances.  “Encumbrance” shall mean any lien, pledge, hypothecation, charge, equities, claims, restrictions, options, proxies, security interest, encumbrance, adverse claim, interference, right of first refusal, preemptive right or restriction, limitation or rights of third parties of any nature (including any spousal community property rights, and any restriction or limitation on the voting, transfer, receipt of any income derived from, or on the use of any security or other asset or any restriction or limitation on the possession, exercise or transfer of any other attribute of ownership of a security), other than the proxy and right of first offer granted by the Seller to Del-Ta Engineering Equipment Ltd. (“Del-Ta”) under sections 2 and 4 of that certain Shareholders Agreement between the Seller and Del-Ta and dated October, 2006 as amended (the “Existing Shareholders Agreement”). The Seller has neither sold, pledged, Encumbered or otherwise transferred, nor undertook or promised to do so (whether by operation of law or otherwise, including, without limitation, transfers pursuant to any decree of divorce or separate maintenance, any property settlement, any separation agreement or any other agreement with a spouse) the Purchased Shares or any interests therein to any person, other than this Agreement.
 
3.3.           The Purchased Shares constitute to Seller's best knowledge 7% of the Company’s issued and outstanding share capital as of the Closing. The number of Ordinary Shares set forth in the first recital to this Agreement constitute all of the shares or other securities over which any voting or dispositive power is held by the Seller and Seller does not own, beneficially or otherwise, nor control, directly or indirectly, any other share capital of, or other securities, equity or ownership interest in the Company (including, without limitation, (i) any outstanding options, warrants, purchase rights, subscription rights, conversion rights, exchange rights or other similar contracts relating to securities of the Company, or (ii) outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to securities of the Company). The Purchased Shares are not subject to any shareholders agreement, voting agreements, proxies, trusts or other agreement or understandings relating to any attribute thereof, including, the voting or disposition thereof, other than the Existing Shareholders Agreement. Any proxies heretofore given in respect of the Purchased Shares are not irrevocable, do not attach to the Purchased Shares after transfer, and any such proxies are or shall be revoked by the Closing. Other than as set forth in Section 6.2.2, there are no transfer restrictions or right of first refusal, right of first offer, tag along or other similar rights applicable to the Purchased Shares. A copy of the Existing Shareholders Agreement, including the amendments thereto, are attached hereto as Exhibit 3.3. The Existing Shareholders Agreement (including the amendments thereto prior to the date hereof) was not amended, supplemented or modified, orally or in writing, and there are no other understandings or arrangements relating thereto between Seller and Del-Ta or any of its affiliates.
 
 
- 3 -

 
 
3.4.           The execution and delivery by the Seller of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, require Seller to obtain or deliver any notice, consent, waiver, approval, order or authorization or permit of, or registration, declaration or filing with, or notification to, any court, administrative agency, commission, governmental or regulatory authority or any other person, other than as set forth in Section 6.2.2 and filings required under the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder in connection with the change in Seller's ownership of Ordinary Shares, which filings shall be solely the responsibility of Seller.
 
3.5.           The execution and delivery by the Seller of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, conflict with, or result in any violation of, or default under (with or without notice or lapse of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation (other than as set forth in Section 6.2.2 hereto) or loss of any benefit, under the Articles of Association of the Company, any agreement, law, rule, regulation, order, judgment or decree applicable to the Seller or that apply to the Purchased Shares or by which the Purchased Shares are bound, or to the knowledge of the Seller, any agreement, law, rule, regulation, order, judgment or decree applicable to the Seller.
 
3.6.           There is no suit, action, proceeding, claim or investigation, decrees, orders, judgments or legal proceeding of any nature, pending, or, to Seller’s knowledge, threatened against the Seller or the Purchased Shares, that seeks to prevent Seller from executing, delivering or performing the Transaction Documents and the transactions contemplated hereby and thereby, or that apply to the Purchased Shares or by which the Purchased Shares are bound.
 
3.7.           No agent, broker, finder, investment banker, person or firm acting in a similar capacity on Seller’s behalf or under the Seller’s authority is, nor will it be, entitled to any brokerage or finder’s fee or any other commission or similar fee, directly or indirectly, in connection with the origin, negotiation or execution of the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby, which would be required to be paid by the Purchaser or the Company.
 
3.8.           There are no agreements, instruments, undertakings or documents between the Company or its affiliates, on the one hand, and the Seller or its affiliate on the other hand, except as listed in Schedule 3.8 ("Seller Agreements"), complete and accurate copies of which have been delivered to Purchaser, and Seller and his affiliates have no other rights or privileges to receive compensation, payments, assets or any other benefits from the Company or its affiliates nor do they have any interests or rights in any assets, operations or activities of the Company of its affiliates. Seller represents that Seller Agreements are in full force and effect, and that neither the Seller, nor to his best knowledge, the Company, is in breach of the provisions of each of Seller Agreements. Neither the Seller, nor his heirs, executors, administrators, successors or assigns have any Claims (as defined below) against the Purchaser, the Company and their respective affiliates, shareholders, officers and directors and each of their respective heirs, executors, administrators, successors and assigns (collectively, the “Other Entities”) with respect to (i) such Seller Agreements or the performance by the Company of any obligation or liability under Seller Agreements or of any other provision of such agreements; or (ii) any matters, causes, acts, conduct, claims, circumstances or events occurring or failing to occur at or prior to the date hereof. “Claims” shall mean any and all actions or causes of action, suits, claims, liabilities, losses, obligations, agreements, promises, debts, damages, diminutions in value, costs and expenses, judgments, rights and demands, whether fixed or contingent, known or unknown, in law or in equity. It is hereby clarified that the aforesaid does not derogate from any future right the Seller may have to claim against the Company or Other Entities in the event that any of the provisions of Seller Agreements or any liabilities, obligations or rights under such Seller Agreements will not be fully fulfilled, performed or respected by the Company.
 
 
- 4 -

 
 
3.9.           Seller agreed to sell the Purchased Shares to the Purchaser at the purchase price provided for herein notwithstanding any possible knowledge differential between the parties, any potential or prospects each party may view for the Company, any potential future role of Purchaser in the corporate governance of the Company, and any potential future appreciation, benefit or privileges relating to the Ordinary Shares, and accordingly Seller hereby irrevocably waives any right, claim or demand that may arise as a result thereof against the Other Entities.
 
4.             Representations and Warranties of the Purchaser.  The Purchaser hereby represents and warrants as follows:
 
4.1.           It is duly incorporated and validly existing under the laws of its jurisdiction of incorporation or formation.
 
4.2.           It has the requisite corporate power and authority to enter into the Transaction Documents to which it is a party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of such Purchaser. The Transaction Documents to which it is a party have been duly executed and delivered by it and, assuming the due authorization, execution and delivery by the other parties hereto, constitute its valid and binding obligations, enforceable against it in accordance with their terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.
 
4.3.           The execution and delivery by it of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, require such Purchaser to obtain or deliver any notice, consent, waiver, approval, order or authorization or permit of, or registration, declaration or filing with, or notification to any court, administrative agency, commission, governmental or regulatory authority or any other person, that has not been, or will not be, obtained by the Closing.
 
4.4.           The execution and delivery of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, conflict with, or result in any violation of or default under (with or without notice or lapse of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation or loss of any benefit under any provision of such Purchaser’s incorporation or formation documents; or any law, rule, regulation, order, judgment or decree applicable to it.
 
4.5.           There is no suit, action, proceeding, claim or investigation, decrees, orders, judgments or legal proceeding of any nature, pending, or, to such Purchaser’s knowledge, threatened against it, that seeks to prevent it from executing, delivering or performing the Transaction Documents and the transactions contemplated hereby and thereby.
 
 
- 5 -

 
 
4.6.           No agent, broker, finder, investment banker, person or firm acting in a similar capacity on such Purchaser’s behalf or under its authority is, nor will it be, entitled to any brokerage or finder’s fee or any other commission or similar fee, directly or indirectly, in connection with the origin, negotiation or execution of the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby, which would be required to be paid by any of the Seller.
 
4.7.           Purchaser has been provided with a copy of the Existing Shareholders Agreement, and, without limitation of Seller's representations and warranties included in Section 3, Purchaser is familiar with the terms and conditions set forth in the Existing Shareholders Agreement.
 
4.8.           Purchaser agreed to Purchase the Purchased Shares from the Seller at the purchase price provided for herein notwithstanding any possible knowledge differential between the parties and any potential or prospects each party may view for the Company, and accordingly Purchaser hereby irrevocably waives any right, claim or demand that may arise as a result thereof against the Seller.
 
5.
Conditions to Closing.
 
5.1.           Conditions to Closing of each Party. The respective obligations of the Seller and the Purchaser to effect the Closing are subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any of which may be waived, in writing, by mutual written instrument of the Seller and the Purchaser:
 
5.1.1.                No Order. No court or other governmental authority shall have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, executive order, decree, judgment, injunction or other order (whether temporary, preliminary or permanent) which is in effect and which has the effect of preventing, enjoining, restraining, prohibiting or otherwise making this Agreement or the transactions contemplated hereby illegal.
 
5.1.2.                Transfer Restrictions Waiver.  A written waiver from the transfer restrictions pursuant to Section 4.1 of the Existing Shareholders Agreement shall have been obtained in a form acceptable to Purchaser, or the 7 days period for exercise of the rights pursuant to the terms of the Existing Shareholders Agreement shall have lapsed unexercised.
 
5.2.           Conditions to Closing of the Purchaser. The obligations of the Purchaser to effect the Closing are subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions, any of which may be waived, in writing, by the Purchaser:
 
5.2.1.                Representations, Warranties and Covenants. (i) The representations and warranties of the Seller in this Agreement shall have been true and correct on the date hereof and as of the Closing Date with the same effect as if made at and as of the Closing Date, and (ii) the Seller shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by the Seller at or prior to the Closing Date.
 
5.2.2.                Receipt of Closing Deliveries. Each of the agreements, instruments and other documents required to be delivered by the Seller under Section 2.2 shall be in a form as attached to this Agreement, and shall have been received by it.
 
5.2.3.                No Injunctions or Restraints. No permanent restraining orders, temporary restraining order (that was not removed prior to Closing) or permanent injunction or other order issued by any administrative agency, commission, regulatory or governmental authority which has or could have the effect of limiting or restricting the Purchaser’s ownership or voting of the Purchased Shares shall be in effect, nor shall there be pending or threatened any suit, action or proceeding seeking the foregoing.
 
 
- 6 -

 
 
5.2.4.                No Company Material Adverse Effect.  In the event that the Closing has not occurred within 15 days after the date hereof (unless the Closing has not occurred as a result of a breach of this Agreement by Purchaser), no change, fact, circumstance, condition, event or effect has occurred, that individually or when taken together has or could reasonably be expected to have a material and adverse effect on the business, operations, results of operations, assets, liabilities, prospects or condition (financial or otherwise) of the Company and its subsidiaries.
 
5.3.            Conditions to Closing of the Seller. The obligations of the Seller to effect the Closing are subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions, any of which may be waived, in writing, by Seller:
 
5.3.1.                Representations and Warranties. (i) The representations and warranties of the Purchaser in this Agreement shall have been true and correct as of the date hereof and on and as of the Closing Date with the same effect as if made at and as of the Closing Date, and (ii) the Purchaser shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by the Purchaser at or prior to the Closing Date.
 
5.3.2.                Purchase Price. Purchaser shall have deposited the Purchase Price as set forth in Section 2.3.
 
6.
Covenants.
 
6.1.           Additional Documents and Further Assurance. Subject to the terms and conditions of this Agreement and any applicable law, each party hereto, at the reasonable request of another party hereto, shall execute and deliver, or cause to be executed and delivered, such other documents and instruments and do and perform such other actions as may be reasonably necessary or desirable for effecting completely the consummation of the Transaction Agreements and the transactions contemplated hereby and thereby.
 
6.2.           Filings; Notices and Approvals.
 
6.2.1.                As promptly as practicable after the date of this Agreement, the parties shall use their commercially reasonable efforts to deliver and file each notice, report or other document, or obtain the consent or approval, required to be delivered, or filed by such party with, or obtained from any governmental or regulatory authority or any third party, with respect to this Agreement and the other agreements and the transactions entered into on the date hereof or contemplated hereby. Each of the Seller and the Purchaser shall cause all documents that it is responsible for filing with or delivering to any governmental or regulatory authority or any third party under this Section 6.2 to comply as to form and substance in all material respects with the applicable legal requirements and contractual obligations and shall keep each other apprised of the status of any communications with, and any inquiries or requests for additional information from, any governmental or regulatory authority or any third party and shall comply promptly with any such inquiry or request.
 
6.2.2.                Without derogating from the foregoing, within one business day after the date hereof the Seller shall provide the required notice, in a form acceptable to Purchaser, pursuant to Section 4.1 of that certain Existing Shareholders Agreement, and shall thereafter keep Purchaser apprised of any communications with respect thereto, including by providing copies of any documents or notices provided to Seller or his representatives promptly after their receipt by Seller or such or representatives. Seller shall only be permitted to sell the Purchased Shares pursuant to Section 4.1 of that certain Existing Shareholders Agreement if Del-Ta shall have timely and validly exercised its right pursuant to such section and provided that the Purchased Shares are sold to Del-Ta solely at the same price and terms of this Agreement, and Seller shall not be granted any right, benefit or privilege of any kind of nature, directly or indirectly, in connection with such purchase. Notwithstanding anything to the contrary, the content of such notice and the compliance by Seller with the Existing Shareholders Agreement shall be solely the responsibility of Seller and shall not result in any liability to Purchaser.
 
 
- 7 -

 
 
7.
Termination.
 
7.1.           This Agreement may be terminated at or prior to the Closing, only as follows:
 
7.1.1.                By written consent of the parties hereto.
 
7.1.2.                By written notice of the Purchaser or the Seller, referring to the relevant clause of this subsection if:
 
7.1.2.1.                if the Closing Date shall not have occurred by 90 (the “Termination Date”); provided, however, that the right to terminate this Agreement under this Section 7.1.2 shall not be available to any party whose action or failure to act has been a principal cause of or resulted in the failure of the Closing to occur on or before such Termination Date;
 
7.1.2.2.                The right pursuant to Section 4.1 of the Existing Shareholders Agreement shall have been exercised by Del-Ta;
 
7.1.2.3.                there shall be a final non-appealable order of any governmental authority in effect preventing consummation of the transactions contemplated hereby; provided, however, that the right to terminate this Agreement under this Section 7.1.2.3 shall not be available to any party whose action or failure to act has been a principal cause of or resulted in such order preventing the consummation of the transactions contemplated hereby and such action or failure to act constitutes a breach of this Agreement;
 
7.1.2.4.                there shall be any statute, rule, regulation, executive order, decree, judgment, injunction or other order enacted, issued, promulgated, enforced, entered or deemed applicable by any governmental authority that would make this Agreement or the transactions contemplated hereby and thereby illegal.
 
7.1.3.            By written notice of the Purchaser to Seller, referring to the relevant clause of this subsection if:
 
7.1.3.1.                there has been a breach of any representation, warranty, covenant or agreement of the Seller contained in this Agreement such that if Closing were to occur on the date of such termination such breach would result in the failure of any of the conditions set forth in Sections 5 hereof to be satisfied and such breach has not been cured within ten (10) days after written notice thereof to the Seller; provided, however, that no cure period shall be required for a breach which by its nature cannot be cured;
 
7.1.3.2.                there shall be statute, rule, regulation or order enacted, promulgated or issued or applicable to the transactions contemplated hereby by any governmental authority, which has or could have the effect of limiting or restricting the Purchaser’s ownership or voting of the Purchased Shares;
 
 
- 8 -

 
 
 7.1.3.3.                Any of the conditions in Sections 5.2.3 or 5.2.4 is not or is reasonably expected not to be satisfied by the Termination Date;
 
7.1.4.                By written notice of the Seller to Purchaser if there has been a breach of any representation, warranty, covenant or agreement of the Purchaser contained in this Agreement such that if Closing were to occur on the date of such termination such breach would result in the failure of any of the conditions set forth in Sections 5 hereof to be satisfied and such breach has not been cured within ten (10) days after written notice thereof to the Purchaser; provided, however, that no cure period shall be required for a breach which by its nature cannot be cured.
 
7.2.           Effect of Termination. In the event of termination of this Agreement as provided in Section 7.1 or 1.4 hereof, this Agreement shall forthwith become void and there shall be no liability or obligation on the part of the Purchaser or the Seller, or their respective employees, agents or shareholders, if applicable, except that the provisions of Section 8 and this Section 7.2 shall remain in full force and effect and survive any termination of this Agreement pursuant to the terms of this Section 7, and except to the extent that such termination results from a material breach by the other party of any representation, warranty or covenant set forth in this Agreement.
 
8.
General.
 
8.1.           Expenses. Each party shall bear its own costs and expenses incurred with respect to the negotiation, execution, delivery and performance of this Agreement.
 
8.2.           Entire Agreement. This Agreement and the exhibits and schedules attached hereto, and the documents and instruments and other agreements among the parties referenced herein, constitute the full and entire understanding and agreement between the parties with respect to the subject matters hereof and thereof, and supersedes any prior understandings, agreements, or representations by or among the parties, written or oral, to the extent they relate in any way to the subject matter hereof.
 
8.3.           Amendment. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the parties hereto. Any amendment or waiver effected in accordance with this Section shall be binding upon all parties of this Agreement and their respective successors and assignees.
 
8.4.           Press Releases.  No party shall issue any statement or communication to any third party (other than their respective agents, partners, affiliates and representatives that are bound by confidentiality restrictions) regarding this Agreement, its existence and content, or the transactions contemplated hereby, including, if applicable, the termination of this Agreement and the reasons therefor, without the consent of the other parties hereto, except as required to comply with applicable legal requirements and the rules of any stock exchange.
 
8.5.           Remedies. Any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy.
 
8.6.           Assignment. Neither this Agreement, nor any rights, interests or obligations under this Agreement may be assigned or transferred, in whole or in part, by operation of law or otherwise by any party hereto, without the prior consent in writing of the other party hereto, and any such assignment without such prior written consent shall be null and void, except that this Agreement or any of the rights, interests or obligations under this Agreement may be assigned by Purchaser, upon notice to the other party, to an affiliate thereof or a lender providing financing in connection with this transaction. Subject to the foregoing, this Agreement shall inure to the benefit of, and be binding upon, and be enforceable by, the parties hereto and their respective successors, assigns, heirs, executors, and administrators.
 
 
- 9 -

 
 
8.7.           Viola Designation. The Purchaser (“Executing Party”) is signing this Agreement on behalf of itself or as a nominee or trustee of an affiliate thereof, as shall be indicted in writing to the Seller prior to the Closing.  In case this Agreement is signed by the Executing Party as a nominee or trustee, then any reference to “Viola” hereunder shall refer to such affiliate, as if an original party hereof, and the Executing Party shall have no further rights or obligations hereunder.
 
8.8.           Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Israel, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. Each of the parties hereto irrevocably consents to the exclusive jurisdiction and venue of any competent court located in Tel-Aviv-Jaffa, Israel in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, agrees that process may be served upon them in any manner authorized by the laws of the State of Israel for such persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction and such process.
 
8.9.           Definitions. When used herein: the words “include,” “includes” and “including” shall be deemed in each case to be followed by the words “without limitation”; the words “herein,” “hereof,” “hereto” and “hereunder” and words of similar import, shall refer to this Agreement as a whole and not to any particular provision of this Agreement; the word “person(s)” shall include an individual, corporation, partnership, association, trust, enterprise or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof; the phrasebeneficial ownership of any securities or “own” (and phrases of similar import) shall mean beneficial ownership for purposes of Rule 13d-3 under the Exchange Act (and for the purposes of Rule 13d-3(d)(1)(i) as if the right to acquire beneficial ownership of such security would have been within 60 days); the word “affiliate(s)” (and words of similar import) shall mean as set forth in Rule 405 promulgated under the Securities Act of 1933, as amended; and the word “group” shall mean any group of persons acting together in the manner described in Rule 13d-5(b)(1) of the Exchange Act.  Unless the context otherwise requires, words denoting the singular number only shall include the plural and vice versa.  "Business Day" (whether or not used as a capitalized term) shall mean each day that is not a Friday or Saturday, or on which banking institutions located in Tel Aviv, Israel are authorized or obligated by law or order to close.
 
8.10.           Interpretation. The headings in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. The recitals, exhibits and schedules form part of this Agreement and shall have the same force and effect as if expressly set out in the body of this Agreement, and any reference to this Agreement shall include the exhibits and schedules hereto. Each of the parties acknowledges that it had assessed the risk, uncertainties and benefits of the transactions contemplated by this Agreement and each Transaction Document to which it is a party, and that it was represented by legal counsel in the negotiation, execution and delivery of the Transaction Documents. Accordingly, and based on the foregoing facts, among other factors, each party acknowledges and agrees that, for purposes of interpreting this Agreement or any other Transaction Document, no party has had any preference in the design of the provisions of this Agreement (within the meaning of Section 25(b1) of the Contracts Law (General Part), 1973 (as amended).
 
 
- 10 -

 
 
8.11.           Severability. If any provision of this Agreement or the application thereof becomes or is declared by a court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. In addition, if any particular provision contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.
 
8.12.           Notices. All notices and other communications hereunder shall be in writing and shall be shall be emailed, faxed or mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger, addressed to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
 
 
8.12.1.
if to the Purchaser, to:
 
Viola Private Equity
Ackerstein Towers, Building D
12 Abba Eban Ave.
Hertzliya Pituach Israel
Attention:              Harel Beit-On
Telephone No.:     (972)-(9)-9720433
Facsimile No.:        (972)(9)-9594952
Email:                      harelb@violape.com                                                      

with a mandatory copy to (which shall not constitute notice):

Meitar Liquornik Geva Leshem Tal
16 Abba Hillel Road Ramat Gan 52506, Israel
Attention:              Dan Shamgar, Advocate
                               Shira Azran, Advocate
Telephone No.:     (972)-(3)-610-3100
Facsimile No.:        (972)-(3)-6103-111
Email:                     dshamgar@meitar.com
                                sazran@meitar.com
 
 
8.12.2.
if to the Seller, to:
 
62 Pinkas St. Tel Aviv 62157
Telephone No.:     (972)-(3)-6056555
Facsimile No.:       (972)-(3)-6056555                                
Email:                     david@rrsat.com

with a mandatory copy to (which shall not constitute notice):

Furth, Wilensky, Mizrachi, Knaani – Law Offices
1 Azrieli Center, Tel Aviv 67021, Israel
Attention:             Udi Knaani, Advocate
                              Orly Samuelov, Advocate
Telephone No.:    (972)-(3)-6070800
Facsimile No.:       (972)-(3)-6097797
Email:                     udi@fwmk-law.co.il
                               orly@fwmk-law.co.il
 
 
- 11 -

 
 
Any notice sent in accordance with this Section 8.12 shall be effective (i) if mailed, seven (7) business days after mailing, (ii) if by airmail two (2) business days after delivery to the courier service, (iii) if sent by messenger, upon delivery, and (iii) if sent via email or facsimile, upon transmission and electronic confirmation of delivery or (if transmitted and received on a non-business day) on the first business day following transmission and electronic confirmation of delivery; provided, however, that any notice of change of address shall only be valid upon receipt.
 
8.13.           Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and enforceable against the parties actually executing such counterpart, and all of which together shall be considered one and the same agreement, it being understood that all parties need not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile transmission or by electronic delivery in .pdf format or the like shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original.
 
- Signature Pages Follow -
 
 
- 12 -

 
 
IN WITNESS WHEREOF, the parties have caused this Share Purchase Agreement to be duly executed as of the date first written above.
 
 
Viola P.E. GP Ltd.
 
By: /s/ Jonathan Kolber
Name: Jonathan Kolber
Title: Authorized Signatory
 
By: /s/ Harel Beit-On
Name: Harel Beit-On
Title: Authorized Signatory

 
David Rivel
 
By: /s/ David Rivel
Name: David Rivel

 
- 13 -

 
 
To: Viola P.E. GP Ltd.
(subject to Section 8.7 of the Agreement (as defined below) the “Purchaser”)

Dear Sirs,

I, the undersigned, being the spouse of Mr. David Rivel (the “Seller”), hereby irrevocably acknowledge, consent and represent to you, in connection with your acquisition of the Purchased Shares (as defined below), as follows:
 
1.           I have been apprised of and hereby approve and accept all the terms and conditions of that certain Share Purchase Agreement of even date hereof (the “Agreement”) by and among the Seller and the Purchaser, pursuant to which the Seller shall sell, transfer, assign, convey and deliver to the Purchaser all of the right, title and interest of each of the Seller in and to the Purchased Shares (as defined therein).
 
2.           I hereby consent to the Seller's entering into the Agreement, and all other Transaction Documents (all as defined in the Agreement), and consummating the transactions contemplated thereby, including without limitation, the transfer and sale by the Seller of the Purchased Shares, pursuant to the terms of the Agreement.
 
3.           I hereby irrevocably agree to be bound by all the terms and conditions of the Agreement and all other Transaction Documents to which the Seller is a party, and further agree that any community property interest I may have in Seller’s beneficial interests in the Purchased Shares or Shares will be similarly bound by the Agreement as the Seller.
 
4.           I understand and acknowledge that the Purchaser is entering into the Agreement in reliance upon my execution of this letter. My agreement shall be irrevocable and shall survive my bankruptcy, death, adjudication of incompetence or the like.
 
5.           I am executing this letter in my own free will and after being independently made fully aware of my rights.
 
Dated: 4.4.2013
 
Signature of Spouse: /s/ Yaffa Rivel
   
Printed Name: Yaffa Rivel
   
ID Number: 064521701
 
- 14 -


EX-2 3 exhibit_2.htm EXHIBIT 2 exhibit_2.htm


Exhibit 2
 
SHAREHOLDERS AGREEMENT
 
THIS SHAREHOLDERS AGREEMENT (the “Agreement”) is made as of this 4th day of April, 2013, by and between Viola P.E. GP Ltd., an Israeli Company (“Viola”) and Mr. David Rivel (“Rivel”).
 
WHEREAS, RRSAT GLOBAL COMMUNICATIONS NETWORK LTD. (the “Company”) is an Israeli public company, whose Ordinary Shares, nominal value NIS 0.01 each (the “Ordinary Shares”), are traded on the “NASDAQ” Stock Exchange in New York, USA (“Nasdaq”);
 
WHEREAS, subject to the consummation of the transactions contemplated under that certain Share Purchase Agreement dated as of the date hereof by and between Viola and Rivel (“Rivel Agreement” and the “Rivel Closing”, respectively), Viola will purchase at the closing thereof Ordinary Shares representing approximately 7% of the issued and outstanding share capital of the Company as of the date of such closing; and
 
WHEREAS, Viola and Rivel (each, and their Permitted Transferees, and any other transferee that subsequently becomes a party to this Agreement a “Shareholder” and, collectively, the “Shareholders”) wish to agree on the matters set forth in connection with their holdings of Ordinary Shares of the Company.
 
NOW, THEREFORE, in consideration of the mutual promises contained in this Agreement, the parties hereto agree as follows:
 
1.
Voting Undertaking and Proxy.
 
1.1.              Rivel hereby agrees, at any annual, extraordinary, or special meeting of the shareholders of the Company and at any postponement(s) or adjournment(s) thereof, or pursuant to any consent in lieu of a meeting or otherwise (each, a “Meeting”), to vote (or cause to be voted) all of the Ordinary Shares of the Company (including without limitation, Ordinary Shares owned following the exercise, conversion or exchange of any options or warrants to purchase Ordinary Shares, or other securities convertible into, or exercisable for, Ordinary Shares), now or hereafter beneficially owned by such Shareholder and its affiliates (collectively, the “Shares”), as directed by Viola, for as long as Viola and its affiliates beneficially own at least 5% of the Company’s issued and outstanding share capital.
 
1.2.              At or prior to the Rivel Closing (and as a condition to the obligations of Viola to consummate the Rivel Closing), Rivel shall and shall cause any of his affiliates that beneficially own Shares and the record holder of any such Shares to deliver to Viola a validly executed irrevocable proxy, in the form attached hereto as Exhibit 1.2. To the extent that the Shares are held electronically, then Rivel shall and shall cause any of his affiliates holding Shares to receive from the bank, broker or other registered holder with which the Shares are deposited or by which they are held to execute an irrevocable proxy to Rivel or directly to the Viola, in each case, in the form attached hereto as Exhibit 1.2. Without derogating from the foregoing, prior to each Meeting, Rivel shall and shall cause any of his affiliates that beneficially own Shares and the record holder of such Shares to deliver a proxy for such Meeting in a form prescribed by the Company or as reasonably requested by Viola, accompanied by confirmation of ownership of such Shares for purposes of voting at the Meeting from the bank, broker or other registered holder with which the Shares are deposited or by which they are held. The use by Viola and/or any of its affiliates of the irrevocable proxy pursuant to this Section 1.2 with respect to any Meeting shall be subject to the provisions of this Section 1.  Rivel understands and acknowledges that Viola is entering into the Rivel Agreement in reliance upon Rivel's execution, delivery and performance of this Agreement. The irrevocable proxy set forth in this Section 1 is given to secure the performance of the duties of Rivel hereunder. Rivel hereby further affirms that unless this Agreement is terminated in accordance with its terms, the irrevocable proxy(ies) pursuant hereto may under no circumstances be revoked without the prior written consent of Viola. As long as Rivel holds Ordinary Shares constituting at least 2.5% of the issued and outstanding share capital of the Company (unless the matter was discussed by the Board of Directors of the Company and Rivel was serving as a director of the Company), then prior to any general meeting of shareholders in which the Shares are voted by Viola pursuant to the proxy under this Section 1.2, a representative of Viola shall confer with Rivel on the matters to be voted upon at such general meeting, provided that Viola shall not be required to vote the Shares in the manner suggested by Rivel, and provided further, that failure to confer with Rivel as described above, for any reason whatsoever, shall not derogate from or restrict the valid and binding effect of the proxy under Section 1.2 and the voting agreement under Section 1.1.
 
 
 

 
 
1.3.              Viola agrees that in each general meeting of shareholders in which members of the Board of Directors of the Company are elected (other than election of external directors), it will vote a portion, of: (i) the Shares subject to the proxy pursuant to Section 1.2 above and the Ordinary Shares subject to a similar proxy from Kardan Communications Ltd. (“Kardan”), (ii) the Ordinary Shares purchased by Viola under the Rivel Agreement, (iii) the Ordinary Shares purchased by Viola under the Share Purchase Agreement (the “Kardan Agreement”) dated on or about the date hereof between Viola and Kardan, and (iv) any additional Ordinary Shares owned by Viola and/or its affiliates at the relevant time (except, with respect to shares referred to in this clause (iv), only to the extent the voting of such shares pursuant to this Agreement would not be inconsistent with or result in a violation by Viola and/or its affiliates of the provisions of any agreement or understanding with any other person) (the “Relevant Shares”), in favor of the appointment of Rivel, personally, as a director of the Company with the good faith intention (but not an obligation) that Rivel shall indeed be elected as a director in such vote, provided that in such vote at least 3 directors are elected by Viola to the Board of Directors of the Company. If Viola shall vote any additional Ordinary Shares of the Company purchased by Viola and/or any of its affiliates (in addition to the Relevant Shares) in favor of the appointment of a director designated by Kardan, then the same number of such additional Ordinary Shares shall be voted in favor of the appointment of Rivel provided that in such vote at least 3 directors are elected by Viola to the Board of Directors of the Company. Viola agrees that the portion of the Relevant Shares voted in favor of the appointment of a director designated by Kardan shall not be greater than the portion voted in favor of the appointment of Rivel, provided that in such vote at least 3 directors are elected by Viola to the Board of Directors of the Company. The above provisions of this Section 1.3 shall remain in effect as long as Rivel qualifies with all applicable legal requirements (including, applicable stock exchange rules and regulations and execution of all required certifications by Rivel in order to be duly nominated and serve as a director). Viola shall be subject to the provisions of this Section 1.3 in respect of the voting for the appointment of Rivel as a director only if and as long as Rivel and his affiliates hold, as of such date, the same number of Shares in the Company as held on the date hereof, free and clear of Encumbrance (other than the provisions of this Agreement and except for the Shares sold under the Rivel Agreement) and provided that all such Shares are subject to the provisions of Sections 1.1 and 1.2 hereto. In the event that Rivel is no longer entitled to require that the portion of the Relevant Shares described herein will be voted as described above with respect to his appointment as a director, then Viola may vote all such Relevant Shares for the removal of Rivel from his position as a director, and upon Viola’s request in such circumstances, Rivel undertakes to execute and deliver a resignation letter from his service as a director with an effect as of a date specified by Viola.
 
 
- 2 -

 
 
1.4.              Until such time as that certain Shareholders Agreement between Rivel and Del-Ta Engineering Equipment Ltd. (“Del-Ta”) dated October 5, 2006 as amended (the “Existing Shareholders Agreement”) terminates or expires in accordance with its current terms, the voting by Rivel or the exercise of his voting power in compliance with Section 3 of the Existing Shareholders Agreement shall not be deemed a breach of this Section 1 and Rivel may vote the Shares in accordance with and subject to such Section 3 of the Existing Shareholders Agreement, to the extent such Section 3 is applicable and binding. Rivel undertakes that, unless the Existing Shareholders Agreement terminates in accordance with its terms 30 days after the Rivel Closing, then at the first instance in which Rivel may issue a notice of termination with respect to the Existing Shareholders Agreement (which is expected to occur in April 2013), Rivel shall provide to Del-Ta a notice of termination of the Existing Shareholders Agreement, and shall otherwise use reasonable efforts to cause the termination of such agreement. Rivel shall inform Viola from time to time or upon Viola's request on any developments relating to the termination of the Existing Shareholders Agreement and shall provide Viola copies of any correspondence relating to such matter.
 
1.5.              Without derogating from the provisions of Sections 2 and 3, except in the event of (i) a Public Sale and (ii) a sale made to a third party in compliance with Sections 2 and 3, the provisions of this Section 1 and the obligations hereunder shall attach to the Shares and shall be binding upon any person to which ownership of such Shares shall pass, whether by operation of law or otherwise, including, without limitation, the parties’ heirs, guardians, administrators, successors and assigns, and notwithstanding any transfer of the Shares, the transferor shall remain liable for the performance of all obligations of the transferor hereunder.
 
1.6.              Sections 1.1 and 1.3 shall be subject to and shall be effective from the grant of the approval from the Ministry of Communication under the licenses granted to the Company therefrom with respect to the voting of any Shares that would require such approval pursuant to such licenses, if applicable. If such approval is required, then Viola shall use its commercially reasonable efforts to deliver and file an application for such approval as soon as reasonably practicable after the date hereof and no later than 30 days after the Rivel Closing, and Rivel shall reasonably cooperate with Viola in such filing.
 
1.7.              The Shareholders shall not enter into any agreement or understanding, or amend or waive any existing agreement or understanding with any person the effect of which would be inconsistent with or result in a violation of the provisions and undertakings referred to in this Section 1 and in any proxies heretofore given by any Shareholder in respect of the Shares being revoked.
 
1.8.              For as long as Viola is required, under Section 1.3, to vote the Relevant Shares in favor of the appointment of Rivel as a director in the Company, at least seven days prior to each Meeting at which such vote is to take place, Rivel and Viola will discuss the vote of the Relevant Shares pursuant to Section 1.2, and within 48 hours after such discussion, Viola will indicate to Rivel the manner in which, based on then available information, it preliminarily contemplates that the Relevant Shares will be voted, provided that the final determination by Viola on the allocation of the vote of the Relevant Shares, consistent with Section 1.3, may be made by Viola at a later time up to the time of the Meeting. This provision and Viola’s compliance with it shall in no way derogate from or be a condition to Rivel’s undertaking and the proxy granted pursuant to this Section 1, or Viola’s exercise of its rights pursuant hereto.
 
 
- 3 -

 
 
2.
Standstill.
 
2.1.              Rivel shall not, and shall cause his affiliates not to, directly or indirectly, (i) for a period of two years from the later of the Rivel Closing or the closing under the Kardan Agreement (the “Kardan Closing”) but not later than 27 months after the Rivel Closing (the "Restriction Period"), offer for sale (including short sale), sell, transfer, exchange, tender, create any Encumbrance, assign, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise dispose of, or enter into any contract or arrangement with respect to, or consent to, or offer, any of the foregoing with respect to, any Shares or any interest therein, to any person (other than pursuant to the Rivel Agreement or in a transaction for the sale of all of the Company’s issued share capital (however structured)); (ii) as long as this Agreement is not terminated in accordance with its terms, except as contemplated by or permitted by this Agreement, grant any proxies or powers of attorney, deposit any Shares into a voting trust or enter into a voting agreement, in each case with respect to any Shares; and (iii) as long as this Agreement is not terminated in accordance with its terms, subject any Shares to any shareholders agreement, or other agreement or understandings relating to any attribute thereof, including, the voting or disposition thereof, or amend or waive, or consent to the amendment or waiver of any provision of any existing shareholders agreement or any other agreement or understanding with any person the effect of which would be inconsistent with or result in the violation of the provisions and undertakings in this Agreement. “Encumbrance” shall mean any lien, pledge, hypothecation, charge, adverse claims, restrictions, options, proxies, security interest, encumbrance, or any other rights of third parties that would impose any restriction on the exercise by the Shareholder of sole voting or dispositive power over any security or any other attribute thereof.
 
2.2.              Rivel and his affiliates shall not be deemed in violation of this Section 2 by granting a lien, pledge or charge in the Shares to a financial or banking institution for as long as such financial or banking institutions acknowledges and agrees in writing to Viola to be bound by the provisions of Sections 1, 2, 3 and 4 and that any realization of any such lien, pledge or charge shall be subject to Viola’s rights set forth herein.
 
2.3.              Rivel and his affiliates shall not request that the Company (or any agent thereof) register the transfer (book-entry or otherwise) of any certificated or uncertificated interest representing any of the Shares, unless such transfer is permitted by and made in compliance with this Agreement.
 
2.4.              Rivel shall not be deemed in violation of this Section 2 for the sale of the Purchased Shares (as defined in the Rivel Agreement) pursuant to Section 4.1 of the Existing Shareholders Agreement, if Del-Ta shall have timely and validly exercised its right pursuant to such section and provided that the Purchased Shares are sold to Del-Ta solely at the same price and terms of the Rivel Agreement, and Rivel shall not be granted any right, benefit or privilege of any kind of nature, directly or indirectly, in connection with such sale.
 
3.
Right of First Offer.
 
3.1.              Subject to and without derogating from Section 2 above, at any time, and from time to time after the date hereof, if Rivel and/or any of his respective affiliates which are or become the beneficial owners of any Shares (the “Selling Party”) wishes to sell or otherwise transfer, directly or indirectly (each, a “Transfer”), any Shares (the “Offered Shares”), then such Selling Party shall be required to first offer the Offered Shares to Viola (the “Offeree”) by sending the Offeree a written offer (the “Offer”) specifying: (i) the number of Offered Shares that the Selling Party proposes to Transfer; (ii) a representation and warranty that the Offered Shares proposed to be sold or transferred are and will be, as of the time of their proposed Transfer, free and clear of all Encumbrance; and (iii) the price that the Selling Party intends to receive as consideration for the Offered Shares, which shall be stated in cash, and the requested terms of payment thereof, other than in case of Transfers on any stock exchange (including, without limitation, in open market transactions, through the framework of an accepted “blind trustee” in relation to the sale of shares by interested parties in certain periods, or in accordance with Rule 144 under the Securities Act of 1933) (“Public Sales”), in which case the price for the Offered Shares shall not be higher than the average of the closing price of the Ordinary Shares in the 7 trading days preceding the date of delivery of the Offer (the “Average Market Price”); and (iv) if known at such time, the identity of the prospective transferee and any persons controlling such transferee, and the terms offered, including a copy of any proposal, term sheet, letter of intent or other agreement relating thereto.
 
 
- 4 -

 
 
3.2.              The Offer shall constitute an irrevocable offer made by the Selling Party to Transfer to the Offeree the Offered Shares covered by the Offer, upon the terms specified in the Offer and as described below. If the Offeree wishes to purchase the Offered Shares upon such terms, it shall notify the Selling Party of its agreement to purchase the Offered Shares by no later than 14 business days of receipt of the Offer, or three (3) business days in case of Public Sales, indicating the maximum number of Offered Shares it wishes to so purchase. The Selling Party shall be obligated to sell the Offered Shares to the Offerees only if the acceptance of the Offer by the Offeree, in the aggregate, is in respect of all (but not less than all) of the Offered Shares on the terms and conditions as described in the Offer, other than in case of a Public Sale in which Selling Party shall sell to the Offeree the number of Offered Shares indicated in the Offeree’s acceptance notice in a private transaction on the terms and conditions as described in the Offer.
 
3.3.              Other than in case of a Public Sale in which Section 3.4 shall apply, if the Offeree declines to purchase all (but not less than all) of the Offered Shares upon the terms specified in the Offer or does not notify the Selling Party of its agreement to purchase the Offered Shares within the applicable acceptance period mentioned above, then the Selling Party may Transfer all the Offered Shares (but not less than all) to a third party, provided that such Transfer is consummated (i) at a price that is not lower than that specified in the Offer, and on other terms (including, payment terms and any other rights, benefits or privileges provided to the transferee or its affiliates) that are not more favorable to the purchaser than those specified in the Offer, (ii) within 90 days following the expiration of the foregoing applicable acceptance period, and (iii) with respect to any transfer pursuant to an Offer made prior to the expiration of the Restriction Period (except for a Public Sale) the transferee agrees to be bound by the terms of this Agreement to the same extent as the respective Shareholder that effected the Transfer, as if it were an original party hereto, by delivering a counterpart of this Agreement to the other parties hereto and by delivering the proxies required under Section 1 above.
 
3.4.              In case of a Public Sale, if the Offeree accepts the Offer with respect to part but not all of the Offered Shares, declines to purchase any Offered Shares upon the terms specified in the Offer or does not respond to the Offer within the applicable period mentioned above, then the Selling Party may Transfer the Offered Shares or the remaining Offered Shares that were not accepted by the Offeree, provided that such Transfer is consummated (i) at a price that is not lower than that specified in the Offer, and on other terms (including, payment terms and any other rights, benefits or privileges provided to the transferee or its affiliates) that are no more favorable to the purchaser than those specified in the Offer, and (ii) within 30 business days following the expiration of the foregoing applicable acceptance period.
 
3.5.              Any transaction contemplated under the Offer that is not consummated by the Selling Party in compliance with subsections 3.3 or 3.4, as applicable, shall require the Selling Party to again comply with the terms and conditions of this Section 3.
 
3.6.              If the Offeree agrees to purchase the Offered Shares upon the terms specified in the Offer, the Selling Party shall sell the Offered Shares to the Offerees against payment by the Offeree of the aggregate consideration as specified in the Offer, subject to any tax withholding required pursuant to applicable law. The closing of the purchase of the Offered Shares shall take place on the later of (i) the 14th business day following the acceptance of the Offer by the Offeree, or (ii) the third business day after such time as the regulatory approvals and requirements with respect to the purchase of such Offered Shares (if any) shall have been satisfied (other than the internal corporate approvals of each of the parties to such transaction which shall be obtained at the entry into such transaction), at such place in Israel as the relevant parties shall agree.
 
 
- 5 -

 
 
3.7.              Any change of control (meaning herein the acquisition or holding of more than 50% of the voting power and a majority of the power to elect directors) of the legal or beneficial owner of the Shares or of any person or entity that controls, directly or indirectly, in any manner whatsoever, such legal or beneficial owner of the Shares, shall constitute a Transfer of all of the Shares held by such person, which Transfer must be conducted in compliance with this Section 3, including the requirement to make an Offer to the Offeree under this Section 3, and the purchase price of the Offered Shares in such case for this purpose shall be the Average Market Price.
 
3.8.              In the event that Rivel proposes to create an Encumbrance that is otherwise permitted pursuant to this Agreement, then such Encumbrance shall be permitted only if the person in favor of which the Encumbrance is created or to which it is granted acknowledges and agrees in a written document delivered to Viola to be bound by the provisions of Sections 1, 2, 33 and  4 and that any realization of any Encumbrance is subject to the rights set forth in Sections 1 and 3.
 
3.9.              The Offeree shall be entitled to apportion or assign its right to purchase Offered Shares to be purchased among its affiliates and Permitted Transferees as well as third parties designated by the Offeree.
 
3.10.             The provisions of Section 3 shall not apply to Transfers pursuant to Section 5 (Permitted Transferees) or a transaction for the sale of all of the Company’s issued share capital (however structured).
 
3.11.              Notwithstanding anything to the contrary in Section 10.14, any notice that a party is required to send to the other party pursuant to this Section 3 or pursuant to Section 4 will only be delivered and considered effective: (i) if sent by messenger, upon delivery; (ii) if sent by electronic mail or facsimile, upon transmission and electronic confirmation of delivery or (if transmitted and received on a non-business day or not during normal business hours at the place of recipient) on the first business day following transmission and provided that the sender confirms by telephone that the notice was received by the recipient.
 
3.12.               Allocation of Sales under Rule 144. If at any time during the term of this Agreement, either Shareholder files with the US Securities and Exchange Commission a Form 144, to allow such Shareholder to sell Shares in brokered transactions under Rule 144 promulgated under the US Securities Exchange Act of 1934 (the “Exchange Act”), then such Shareholder will notify the other Shareholder in writing of such filing within two business days thereafter. The other Shareholder shall notify the first Shareholder in writing, within two business days after receipt of the written notification from the first Shareholder, whether it intends to file a Form 144, in which case the second Shareholder will file its Form 144 within two business days after providing such notification to the first Shareholder. If the second Shareholder does not file such Form 144, then the first Shareholder may sell in brokered transactions under Rule 144 and while complying with the provisions of this Agreement, during the three-month period covered by its Form 144, the maximum number of Shares permitted to be sold by the Shareholders under Rule 144 during such period. If both Shareholders file Forms 144, then each Shareholder may sell, together with their respective affiliates, during the three-month periods covered by their Forms 144, one half of the maximum amount of shares permitted to be sold under Rule 144 during such period. By the end of the first 30-day period of the foregoing three-month period covered by its Form 144, each Shareholder will notify the other Shareholder whether it intends to exercise its sale rights referred to above in full through the expiration of such three-month period. A Shareholder that does not so notify the other Shareholder will be deemed to have elected not to sell its respective remaining amount at such time, thereby enabling the other Shareholder that did notify of its intent to sell, to sell its entire remaining portion as well as the other Shareholder’s remaining portion. If neither Shareholder notifies the other Shareholder as set forth herein, both Shareholders may continue selling their portions under the equal allocation described above.
 
 
- 6 -

 
 
4.
Tag Along
 
4.1.              Without derogating from Section 3 above, at any time, and from time to time after the date hereof, if any Selling Party (which term, for the purpose of this Section 4 shall include also Viola and its affiliates which are or become the beneficial owners of any Shares) wishes to Transfer any Offered Shares to a proposed third party purchaser (the “Proposed Purchaser”), other than in a Public Sale (provided that a Transfer pursuant to a registration statement shall not be deemed to be a Public Sale and shall be subject to this Section 4), and if, to the extent applicable, the Offeree declines to purchase the Offered Shares in their entirety upon the terms specified in the Offer, or shall have not notified the Selling Party in writing of their agreement to purchase the Offered Shares within the applicable acceptance periods mentioned in Section 3.2, then it shall send to each other Shareholder that holds at least 2% of the issued and outstanding share capital of the Company at such time (each, a “Tag Along Shareholder”) a written notice in which the Selling Party shall specify the following information (the “Tag Along Offer”): (i) the number of shares that the Selling Party proposes to Transfer (the “Tag Along Shares”); and (ii) the price that the Selling Party will receive in respect of the Tag Along Shares, which shall be stated in cash, and the requested terms of payment thereof; (iii) the proposed date for sale of the Tag Along Shares; and (iv) the identity of the proposed third party purchaser and any persons controlling such proposed purchaser. For the purpose of this Section 4 any Permitted Transferees of the Selling Party, which are or become the beneficial owners of Ordinary Shares shall not be deemed a Tag Along Shareholder in a Transfer by such Selling Party.
 
4.2.              Each Tag Along Shareholder shall have the right to notify the Selling Party in writing, within seven (7) business days after it is informed of the Tag Along Offer, of its decision to exercise its tag along right pursuant to this Section 4 (the “Tag Along Exercise Notice”), in an amount of Ordinary Shares of up to the Tag Along Shareholder’s Pro-Rata Portion (as defined below), as the Tag Along Shareholder shall specify in the Tag Along Exercise Notice, and on the same terms and conditions to the Tag Along Shareholder as set forth in the Tag Along Offer.
 
4.3.              A Tag Along Shareholder’s ”Pro-Rata Portion” shall mean the number of Tag Along Shares multiplied by a fraction, (i) the numerator of which shall be the number of Ordinary Shares held by such Tag Along Shareholder and (ii) the denominator of which shall be the total number of Ordinary Shares held by all Tag Along Shareholders as of such date, plus the total number of Ordinary Shares held by such Selling Party as of such date, plus if Viola or its affiliates is the Selling Party, the total number of Ordinary Shares held by any other shareholder of the Company that has tag along rights with respect to such Tag Along Offer.
 
4.4.              Rivel represents and warrants that as of Rivel Closing, the Agreement, dated as of October 5, 2006 among Del-Ta, Rivel and Kardan (the “Existing Tag Along Agreement”) is no longer in effect with respect to Rivel.
 
4.5.              In the event that any Tag Along Shareholder exercises its right hereunder, the Selling Party shall use commercially reasonable efforts to cause the Proposed Purchaser to add such number of Ordinary Shares indicated in the Tag Along Exercise Notice(s), in addition to the Tag Along Shares to be purchased by the Proposed Purchaser from the Selling Party, as part of the sale agreement; or, in the event that the Proposed Purchaser declines to purchase the total number of Ordinary Shares that the parties wish to sell, then the number of Tag Along Shares proposed to be sold by the Selling Party shall be accordingly reduced to the extent necessary to provide for the Transfer by the Tag Along Shareholder(s) of its/their Ordinary Shares as indicated in its/their Tag Along Exercise Notice(s); provided however, that a Tag-Along Shareholder exercising its tag along right pursuant to this Section 4 in respect of less than its Pro-Rata Portion shall sell such lower amount, with the balance thereof to be allocated pro-rata among the other Tag-Along Shareholder(s) and the Selling Party.
 
 
- 7 -

 
 
4.6.              To the extent the Tag Along Shareholder exercised its right under this Section4, (i) its Transfer of Ordinary Shares to the Proposed Purchaser shall be made on the same terms and conditions to the Tag Along Shareholder as those on which the Selling Party is transferring its Tag Along Shares, and (ii) such Tag Along Shareholder shall promptly execute all documents and instruments that are required by the Proposed Purchaser.
 
4.7.              In the event the transactions contemplated by a Tag Along Offer shall not be consummated by the Selling Party for any reason, the Tag Along Shareholder(s) shall not be required to sell any Ordinary Shares to the Proposed Purchaser. The Selling Party shall have sole discretion in deciding whether or not to consummate the transaction contemplated by the Tag Along Offer (regardless of the exercise by the Tag Along Shareholder of its rights), and shall have no liability towards the Tag Along Shareholders if such transactions are not consummated.
 
4.8.              In the event that the Selling Party proposes to effect a Transfer on terms and conditions less favorable than as set forth in the Tag Along Offer or in the event that the transaction thereunder is not consummated within 90 days after the lapse of the 7 business-day period set forth in Section 4.2 above, then the Selling Party shall not proceed with any Transfer without the Selling Party again complying with the terms and conditions of this Section 4.
 
4.9.              The proceeds of any Transfer made by a Selling Party not in compliance with the provisions of this Section 4 shall be deemed to be held by the Selling Party in constructive trust for each of the Tag-Along Shareholder(s) in an amount representing each such Tag-Along Shareholder(s) Pro Rata Portion.
 
5.
Permitted Transfers.
 
5.1.              Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 2, 3 and 4 above shall not apply to any Transfer of Shares by a Shareholder to its Permitted Transferees (as defined and subject to the conditions set forth below).
 
5.2.              For purposes of this Agreement, “Permitted Transferee” means (i) with respect to a natural person, the spouse and lineal descendant of such person, or trust for the benefit of the foregoing, or a company controlled (meaning herein the holding of a majority of the voting power or a majority of the power to elect directors) by such natural person or any of the foregoing; (ii) in case of an incorporated Shareholder - any affiliate of such Shareholder; (iii) in case of Viola, in addition to the above, any of its current or retired partners or members; any person (and its respective current or retired partners or members) managed or co-managed by the same management company or the same managing general partner or by the person which controls, is controlled by, or is under common control with such management company or managing general partner; or any person or entity that controls, is controlled by, or is under common control with any such person; provided that in each case the Permitted Transferee has agreed in writing to assume and be bound by all of a Shareholder’s obligations hereunder as if it were an original party hereto by delivering a counterpart of this Agreement to the other parties hereto (a “Permitted Transfer”). Any Transfer of Shares effected in violation of this Agreement shall be null and void.
 
 
- 8 -

 
 
5.3.              For all purposes under this Agreement, including for the provisions of Sections 2, 3 and 4, each party and its Permitted Transferees which are or become the holders or owners of Shares, whether directly or beneficially, shall be considered as one party, enjoying jointly (and only jointly) all the rights and jointly and severally assuming all of the obligations pursuant to the terms of this Agreement. If one or more Permitted Transferees of a Shareholder is or becomes the holder or owner of Shares, then the original parties hereto or their successor (and notwithstanding any later Transfer), shall be deemed, for all intents and purposes, to have been granted an irrevocable power of attorney from their respective Permitted Transferees owning or holding Shares with respect to all matters arising under this Agreement and only the original parties hereto or their successor shall be entitled to send or receive any of the notices contemplated herein. Any decision, act or omission by such party shall be binding upon its Permitted Transferees.
 
6.           Share Adjustments. In the event of any share split (bonus shares), share dividend (including any dividend or distribution of securities convertible into share capital), recapitalization, reorganization, combination or other like change with respect to the Company’s shares, or the acquisition or receipt by any Shareholder of additional Ordinary Shares, the provisions of this Agreement shall apply also to any such Ordinary Shares issued to, purchased or otherwise held by the Shareholders.
 
7.           No - Solicitation.
 
7.1.              Rivel shall not, and shall cause its affiliates and their respective employees, officers, directors, agents and other advisors and representatives not to, whether directly or indirectly (i) solicit, initiate, encourage or induce the making, submission or announcement of any Other Proposal (as defined below); (ii) make, or in any way participate, directly or indirectly, in any Other Proposal or Other Transaction (as defined below); (iii) engage or otherwise participate in any discussions or negotiations regarding, or furnish to any person any non-public information with respect to, or take any other action to facilitate any inquiries or the making of any proposal that constitutes or may reasonably be expected to lead to, any Other Proposal; (iii) respond to or engage in discussions with any person with respect to any Other Proposal, except as to the existence of these provisions; (iv) approve, endorse or recommend any Other Proposal; or (v) enter into any letter of intent or similar document or any agreement or commitment contemplating or otherwise relating to any Other Transaction.
 
7.2.              Rivel shall, and shall cause its affiliates and their respective employees, officers, directors, agents and other advisors and representatives to, promptly advise Viola orally and in writing of any request, statement of intent, inquiry, referral or offer received by any of them that could lead to an Other Proposal, the material terms and conditions thereof, and the identity of the person or group making any such request, statement of intent, inquiry, referral, offer or Other Proposal, and shall keep Viola informed in all respects of the status and details (including material amendments or proposed amendments) thereof.
 
7.3.              For the purpose of this Section 7, the following terms shall have the following meanings: “Other Proposal” shall mean any inquiry, offer or proposal (other than an inquiry, offer or proposal by Purchaser or its affiliates), oral or written, relating to any Other Transaction. “Other Transaction” shall mean any transaction or series of transactions, other than the transactions contemplated by this Agreement or the Rivel Agreement, involving: (i) any merger, exchange, consolidation, business combination, plan of arrangement, issuance of securities, acquisition of securities, reorganization, recapitalization, takeover offer, tender offer, exchange offer, purchase, sale (including short sale), transfer, option, proxies or other transaction (A) in which a person or group of persons directly or indirectly acquires beneficial or record ownership of securities representing 10% or more of the outstanding securities of any class of voting securities or debt securities of the Company or any material subsidiary thereof; or (B) in which the Company or any material subsidiary thereof issues securities representing 10% or more of the outstanding securities of any class of voting securities of the Company or any material subsidiary thereof or debt securities; (ii) “solicitation” of “proxies” to vote (as such terms are used in the rules under the Securities Exchange Act of 1934 (collectively, as amended, the “Exchange Act”)) with respect to any Shares, calling or seeking to have called a meeting of shareholders of the Company or execution of any written consent in lieu of such a meeting, submitting a shareholder proposal to the Company or a demand that the Company convene a shareholders’ meeting, or seeking to advise or influencing any person or entity with respect to the voting of any voting securities of the Company; or (iii) seeking control of the management or the Board of Directors of the Company or policies of the Company, or any change which results or is reasonably likely to result in a change in the majority of the persons who constitute the board of directors of the Company.
 
 
- 9 -

 
 
8.
Call Option.
 
8.1.              Viola hereby grants Rivel a call option to purchase the Purchased Shares as defined in the Rivel Agreement purchased at the Rivel Closing and held by Viola (the "Call Option" and the "Call Option Shares", respectively) in consideration for a Purchase Price as defined in the Rivel Agreement, and on the terms set forth in this Section 8.
 
8.2.              The Call Option may be exercised by Rivel with respect to all (and not less than all) Call Options Shares, by delivery to Viola of an irrevocable and binding written notice, during the period commencing on the termination of the Kardan Agreement and ending at 19:00 Israel time on the date that is 30 days thereafter, provided that together with the delivery of such notice Rivel also transfers to an escrow account in the name of MLG&LB Trust Ltd. (the “Escrow Agent”) (which account shall be designated by the Escrow Agent) the full amount of the Purchase Price, which amount shall be held by the Escrow Agent pending the consummation of the Call Option.
 
8.3.              The closing of the Call Option (the "Call Option Closing") shall take place three days after the delivery of the exercise notice and the Purchase Price in accordance with Section 1.28.2, at such place in Israel as the parties shall agree. At the Call Option Closing, Viola shall only be required to deliver a share transfer deed evidencing the transfer of Call Option Shares, free and clear of Encumbrance against receipt in full of the price pursuant to Section 8.1, subject to tax withholding by law unless Viola provides Rivel a valid certificate from the Israeli Tax Authorities providing full exemption from withholding tax (or a lower rate of withholding) or a tax determination from the Israeli Tax Authorities indicating otherwise. If the Call Option Closing is subject to any regulatory approvals then it will be postponed until such approvals are obtained, and if the Call Option Closing is not consummated no later than the 60th day following the delivery of Rivel’s exercise notice, for any reason whatsoever, including failure to obtain any necessary third party or regulatory approvals or consents (but other than breach by Viola of its obligations under this Section 8), then, without limitation of any remedies available to Viola, the Call Option shall expire and terminate and shall have no further force and effect.
 
9.
Term; Termination.
 
9.1.              Each of Viola and Rivel may terminate this Agreement by written notice to the other party commencing on the first date after the Rivel Closing on which Viola and its affiliates and Permitted Transferees hold in the aggregate less than 5% of the Company’s issued and outstanding share capital, or, if the purchase of shares by Viola from Kardan pursuant to the Share Purchase Agreement entered into among such parties on or about the date hereof is consummated, 10% of the Company’s issued and outstanding share capital.
 
 
- 10 -

 
 
9.2.              Viola may terminate this Agreement by written notice to Rivel commencing on the first date on which Rivel and its affiliates and Permitted Transferees hold in the aggregate less than 2.5% of the Company’s issued and outstanding share capital.
 
9.3.              This Agreement shall automatically terminate upon the termination of the Rivel Agreement as a result of the sale of the Purchased Shares (as defined in the Rivel Agreement) to Del-Ta pursuant to Section 4.1 of the Existing Shareholders Agreement. For the avoidance of doubt, as long as the Existing Shareholders Agreement remains in effect, and this Agreement was not terminated under this Section 8, the provisions of the Existing Shareholders Agreement shall continue to apply, while this Agreement shall apply only to the extent that it is not in contradiction to the Existing Shareholders Agreement.
 
9.4.              Without derogating from the foregoing, this Agreement shall automatically terminate upon the consummation of a Liquidity Event (as defined below). Additionally, this Agreement shall terminate as to each Shareholder upon the Transfer (as defined above) of all Shares owned by such Shareholder in compliance with this Agreement.
 
Liquidity Event” shall mean (i) any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, (ii) a merger, consolidation, recapitalization or similar transaction or series of related transactions involving the Company, provided that in each case the Company shareholders immediately prior to such transaction hold less than 20% of the voting securities of the Company (or the surviving or resulting entity) after giving effect to such transaction, or (iii) the sale of all or substantially all of the Company shares (including by way of one or more tender offers), provided that in each case the Company's shareholders immediately prior to such transaction hold less than 20% of the voting securities of the Company (or the surviving or resulting entity) after giving effect to such transaction.
 
10.
Miscellaneous.
 
10.1.              Further Assurances. The parties hereto shall execute and deliver such additional documents and shall take such additional actions (including without limitation procuring such resolutions or regulatory approvals) as may be reasonably necessary to effect the provisions and purposes of this Agreement and giving full effect to the provisions contemplated hereby.
 
10.2.              Fees and Expenses. Each Shareholder shall bear its own legal fees and all related expenses in connection with this Agreement.
 
10.3.              Holding Notice. Rivel shall notify in writing Viola upon any purchase, sale or Encumbrance by it and its affiliates of any Shares, and upon Viola’s request shall certify in writing the Shares then held by it and its affiliates. Viola may include such information in any public filing required to be made by Viola in connection with its holdings in the Company or otherwise.
 
10.4.              Transfer Void. Any Transfer of Shares effected in violation of this Agreement shall be null and void.
 
10.5.              Entire Agreement. This Agreement, the exhibits and the schedules hereto and the documents and instruments and other agreements among the parties referenced herein, constitute the entire agreement among the parties hereto with respect to the subject matter hereof and supersede any other agreement, written and oral, that may have been made or entered into by the Shareholders relating to the transactions contemplated by this Agreement.
 
 
- 11 -

 
 
10.6.              Amendment; Waiver. Any term of this Agreement may be amended (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of all the Shareholders, provided that (i) in the event that Rivel Transfer part but not all of his Shares, then, for purposes of this sentence, any transferee shall not be deemed to be a Shareholder whose consent is required for such amendment, and (ii) in the event that Rivel Transfer all of his Shares, in one or more transactions, to more than one transferee, then for purposes of this sentence, all such transferees (other than transferees in Public Sales) shall constitute together one Shareholder and the consent under this sentence shall be deemed granted if signed by such transferee(s) holding a majority of the Shares currently held by Rivel. The observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) by the party benefiting from such term, and the proviso of the previous sentence shall equally apply. Any amendment or waiver effected in accordance with this Section shall be binding upon all parties of this Agreement and their respective successors and assignees.
 
10.7.              Press Releases. No party shall issue any statement or communication to any third party (other than their respective agents, partners, affiliates and representatives that are bound by confidentiality restrictions) regarding this Agreement, its existence and content, or the transactions contemplated hereby, without the consent of the other parties hereto, except as required to comply with applicable legal requirements and the rules of any stock exchange.
 
10.8.              Remedies. The parties hereby acknowledge that monetary damages may not be a sufficient or adequate remedy for any breach or violation of any of their obligations hereunder and that, in addition to any other remedy which may be available to a party hereunder or in law or equity, and without any wavier or limitation with respect thereto, a party shall be entitled to injunctive and other equitable relief, including specific performance, with respect to any such breach or violation and to enforce specifically the terms and provisions hereof, in any court of competent jurisdiction. Any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy.
 
10.9.              Assignment. Neither this Agreement, nor any rights, interests or obligations under this Agreement may be assigned or transferred, in whole or in part, by operation of law or otherwise by any party hereto, without the prior consent in writing of the other parties hereto, and any such assignment without such prior written consent shall be null and void, except that this Agreement or any of the rights, interests or obligations under this Agreement may be assigned by Viola, upon written notice to the other parties, to one or more affiliates or Permitted Transferees. Subject to the foregoing, this Agreement shall inure to the benefit of, and be binding upon, and be enforceable by, the parties hereto and their respective successors, assigns, heirs, executors, and administrators.
 
10.10.              Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Israel, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. Each of the parties hereto irrevocably consents to the exclusive jurisdiction and venue of any competent court located in Tel-Aviv-Jaffa, Israel in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, agrees that process may be served upon them in any manner authorized by the laws of the State of Israel for such persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction and such process.
 
 
- 12 -

 
 
10.11.              Definitions. The words “include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation”. The words “herein,” “hereof,” “hereto” and “hereunder” and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement; the word “person(s)” shall include an individual, corporation, partnership, association, trust, enterprise or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof; the phrase or wordsbeneficial ownership of any securities or “own” (and words and phrases of similar import) shall include ownership of record or beneficial ownership for purposes of Rule 13d-3 under the Exchange Act (and for the purposes of Rule 13d-3(d)(1)(i) as if the right to acquire beneficial ownership of such security would have been within 60 days); the word “affiliate(s)” (and words of similar import) shall mean as set forth in Rule 405 promulgated under the Securities Act of 1933, as amended; the word “group” shall mean any group of persons acting together in the manner described in Rule 13d-5(b)(1) under the Exchange Act; and the term “business day” (whether or not used as a capitalized term) shall mean each day that is not a Friday or Saturday, or on which banking institutions located in Tel Aviv, Israel are authorized or obligated by law or order to close.
 
10.12.           Interpretation. The headings in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. The recitals, exhibits and schedules form part of this Agreement and shall have the same force and effect as if expressly set out in the body of this Agreement, and any reference to this Agreement shall include the exhibits and schedules hereto. Each of the parties acknowledges that it had assessed the risk, uncertainties and benefits of the transactions contemplated by this Agreement, and that it was represented by legal counsel in the negotiation, execution and delivery of this Agreement. Accordingly, and based on the foregoing facts, among other factors, each party acknowledges and agrees that, for purposes of interpreting this Agreement, no party has had any preference in the design of the provisions of this Agreement (within the meaning of Section 25(b1) of the Contracts Law (General Part), 1973 (as amended).
 
10.13.           Severability. If any provision of this Agreement or the application thereof becomes or is declared by a court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. In addition, if any particular provision contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.
 
10.14.           Notices. All notices and other communications hereunder shall be in writing and shall be shall be emailed, faxed or mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger, addressed to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
 
If to Viola:
Viola Private Equity
Ackerstein Towers, Building D
12 Abba Eban Ave.
Hertzliya Pituach Israel
Attention:              Harel Beit-On
Telephone No.:     (972)-(9)-9720433
Facsimile No.:        (972)(9)-9594952
Email:                     harelb@violape.com
 
 
- 13 -

 

With a copy to (which shall not constitute notice):

Meitar Liquornik Geva Leshem Tal
16 Abba Hillel Rd. Ramat Gan 52506, Israel
Tel:                        (972)-(3)-610-3100
Fax:                        (972)-(3)-6103-111
Attention:            Dan Shamgar, Advocate
Shira Azran, Advocate
Email:                   dshamgar@meitar.com
sazran@meitar.com
If to Rivel:

62 Pinkas St. Tel Aviv 62157
Tel:                        (972)-(3)-6056555
Fax:                        (972)-(3)-6056555                                
Email:                     david@rrsat.com

With a copy to (which shall not constitute notice):

Furth, Wilensky, Mizrachi, Knaani – Law Offices
1 Azrieli Center, Tel Aviv 67021, Israel
Tel:                         (972)-(3)-6070800
Fax:                         (972)-(3)-6097797
Attention:              Udi Knaani, Advocate
  Orly Samuelov, Advocate
Email:                      udi@fwmk-law.co.il
orly@fwmk-law.co.il
 
Without derogating from and subject to Section 3.11, any notice sent in accordance with this Section 10.13 shall be effective (i) if mailed, seven (7) business days after mailing, (ii) if by airmail two (2) business days after delivery to the courier service, (iii) if sent by messenger, upon delivery, and (iii) if sent via email or facsimile, upon transmission and electronic confirmation of delivery or (if transmitted and received on a non-business day) on the first business day following transmission and electronic confirmation of delivery; provided, however, that any notice of change of address shall only be valid upon receipt.
 
10.15.              Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and enforceable against the parties actually executing such counterpart, and all of which together shall be considered one and the same agreement, it being understood that all parties need not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile transmission or by electronic delivery in .pdf format or the like shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original.
 
10.16.              Viola Designation. Viola (“Executing Party”) is signing this Agreement on behalf of itself or as a nominee or trustee of an affiliate thereof, as shall be indicted in writing to Rivel.  In case this Agreement is signed by the Executing Party as a nominee or trustee, then any reference to “Viola” hereunder shall refer to such affiliate, as if an original party hereof, and the Executing Party shall have no further rights or obligations hereunder.
 
[Signature Pages Follow]
 
 
- 14 -

 
 
IN WITNESS WHEREOF, the Shareholders have each caused this Shareholders Agreement to be duly executed as of the date first above written.
 
  Viola P.E. GP Ltd.
 
By: /s/ Jonathan Kolber
Name: Jonathan Kolber
Title: Authorized Signatory
 
By: /s/ Harel Beit-On
Name: Harel Beit-On
Title: Authorized Signatory
 
Mr. David Rivel
 
By: /s/ David Rivel
Name: David Rivel
 
- 15 -


 
EX-4 4 exhibit_4.htm EXHIBIT 4 exhibit_4.htm


Exhibit 4
SHARE PURCHASE AGREEMENT
 
This Share Purchase Agreement (the “Agreement”) is entered into on this 4th day of April, 2013 by and among Kardan Communications Ltd., an Israeli Company (“Seller”); and Viola P.E. GP Ltd., an Israeli Company (the “Purchaser”).

WITNESSETH:

WHEREAS, Seller is the sole owner, beneficial and of record, of 4,233,600 Ordinary Shares, par value NIS 0.01 each, of RRSAT GLOBAL COMMUNICATIONS NETWORK LTD., a company incorporated under the laws of the State of Israel (the “Ordinary Shares” and the “Company”, respectively);

WHEREAS, the Seller wishes to sell, transfer and assign to the Purchaser, and the Purchaser wishes to purchase, assume and receive from Seller, 2,255,053 Ordinary Shares, as may be adjusted pursuant to and in accordance with Section 1.6 below (the “Purchased Shares”) for the consideration set forth herein, subject to the terms and conditions set forth in this Agreement; and

WHEREAS, concurrently with the execution of this Agreement, (i) the Purchaser is entering into a share purchase agreement, providing for the purchase by the Purchaser of Ordinary Shares from Mr. David Rivel (the “Rivel Agreement”); and (ii) the Purchaser and the Seller are entering, on the date hereof, into the Shareholders Agreement in the form attached hereto as Exhibit A (the “Shareholders Agreement”).

NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements contained herein, the parties hereto, intending to be legally bound, agree as follows:
 
1.
Condition Precedent; Purchase and Sale of the Purchased Shares.
 
1.1.           This Agreement shall be valid and effective as of and subject to the consummation of the purchase and sale of Ordinary Shares under the Rivel Agreement (the “Rivel Closing”), except for Sections 2.5 and 8 which shall be binding on the parties.  If the Rivel Closing does not occur by the Termination Date (as defined herein), then this Agreement shall have no force and effect.
 
1.2.           At the Closing (as defined below) and subject to the terms and conditions of this Agreement, the Seller shall, in reliance on the representations and warranties of the Purchaser contained herein, sell, convey, transfer, assign and deliver to the Purchaser, and the Purchaser shall, in reliance on the representations and warranties of the Seller contained herein, purchase and acquire from the Seller, the Purchased Shares together, if applicable, with the Related Assets (as defined below), free and clear of any Encumbrances, in consideration for a gross aggregate purchase price for all Purchased Share equal to US$17,843,985 less the gross amount of all dividends or other distributions effected by the Company following the date hereof and through the Closing in respect of the Purchased Shares (the "Purchase Price" and, when divided by the number of Purchased Shares referred to above, the "Purchase Price Per Share"). At the Closing, the Purchaser shall purchase from the Seller and the Seller shall sell to the Purchaser all (and not part) of the Purchased Shares, and, if applicable, the Related Assets. “Related Assets” shall mean all rights, assets, properties or securities of any kind distributed, issued or granted in respect of, in exchange or in addition to, the Purchased Shares, following the date hereof and through the Closing, and any right or entitlement to receive the same, but excluding distributions to the extent deducted from the Purchase Price as set forth above. Whether or not specifically indicated, any reference to the Purchased Shares in this Agreement shall include, if applicable, the Related Assets.
 
 
 

 
 
1.3.           As soon as reasonably practicable hereafter, the Seller shall provide the required notice ("Sale Notice"), in a form reasonably acceptable to Purchaser, to all parties entitled to receive such Sale Notice pursuant to Section 2 of that certain Agreement between the Seller, David Rivel and Del-Ta Engineering Equipment Ltd. (“Del-Ta”) dated October 5, 2006 (the “Tag Along Agreement”). Notwithstanding anything to the contrary, the content of such Sale Notice and the compliance by Seller with the Tag Along Agreement shall be solely the responsibility of Seller and shall not result in any liability to Purchaser. If a Notice of Joining (as defined therein) is served to the Seller, then the Seller shall, promptly upon receipt thereof, deliver such Notice of Joining to Purchaser, and at the lapse of 14 days from the date of receiving the Sale Notice by each of the parties entitled thereto pursuant to Section 2 of the Tag Along Agreement, the Seller shall deliver to Purchaser a certificate indicating the number of Ordinary Shares to be sold by it and each party receiving the Sale Notice and certifying that the information contained therein is true, correct and complete. In case a Notice of Joining is served to Seller in accordance with the Tag Along Agreement, then: (i) the number of Ordinary Shares and, if applicable, the Related Assets, to be sold by the Seller hereunder shall be reduced by the aggregate number of Ordinary Shares and, if applicable, the Related Assets, elected to be sold by the other party(ies) in accordance with the Tag Along Agreement, and (ii) each such other party serving a Notice of Joining shall be required to sign a joinder to this Agreement, in the form of Exhibit 1.3, pursuant to which such party shall become a “Seller” hereunder and the number of Ordinary Shares to be sold by such party shall be deemed “Purchased Shares” hereunder for all intent and purposes. In the event that a Notice of Joining is served on Seller, however, for any reason whatsoever, the party purporting to join the sale does not comply with any and all requirements hereunder to participate in the sale of the Purchased Shares to Purchaser at the Closing, then notwithstanding the Notice of Joining, the Seller shall sell all the Purchased Shares to Purchaser at Closing without any reduction.
 
1.4.           All taxes due as a result of the sale of the Purchased Shares and, if applicable, the Related Assets, hereunder shall be the sole liability of the Seller. Unless the Seller provides to the Purchaser a valid certificate from the Israeli Tax Authorities providing full exemption from withholding tax (or a lower rate of withholding) or a tax determination from the Israeli Tax Authorities indicating otherwise, at least three (3) business days in advance of the Closing Date, then the Purchaser shall be entitled to deduct and withhold from such payment such amount as required to be deducted and withheld under any applicable law. To the extent that amounts are so withheld, (i) the Purchaser will provide to the Seller written evidence of the transfer of the withheld amounts to the Israeli Tax Authorities and (ii) such withheld amounts shall be treated for all purposes of this Agreement as having been delivered and paid to the Seller in respect of which such deduction and withholding was made.
 
1.5.           In the event of any stock split (bonus shares), consolidation, share dividend (including any dividend or distribution of securities convertible into share capital), reorganization, reclassification, combination, recapitalization or other like change with respect to the Purchased Shares and, if applicable, the Related Assets, occurring after the date hereof and prior to the Closing, all references in this Agreement to specified price per share, type and class of shares, numbers of shares and all calculations provided for that are based upon numbers affected thereby, shall be equitably adjusted to the extent necessary to provide the parties the same economic effect as contemplated by this Agreement prior to such event.
 
1.6.           The number of Purchased Shares indicated in the recital to this Agreement is calculated based on 17,346,561 Ordinary Shares issued and outstanding as of the date hereof. The parties shall verify with the Company immediately prior to the Closing that the number of Ordinary Shares stated above to be Purchased Shares constitutes 13% of the issued and outstanding share capital of the Company as of immediately prior to Closing, and, to the extent such number is incorrect, then the Purchaser may elect (at its discretion) to purchase from the Seller such number of additional Ordinary Shares that will result in the aggregate Ordinary Shares purchased by Purchaser from Seller hereunder constituting 13% of the issued and outstanding share capital of the Company as of immediately prior to Closing; provided that (i) the Purchase Price shall be increased by the product of the number of such additional Ordinary Shares to be so transferred and (A) if the number of Ordinary Shares stated above to be Purchased Shares constitutes less than 13% of the issued and outstanding share capital of the Company as of immediately prior to Closing as a result of the issuance by the Company of Ordinary Shares following the date hereof and prior to the Closing (a “Dilutive Issuance”), the higher of (1) the price per share in such Dilutive Issuance (or, if more than one Dilutive Issuance is consummated between the date hereof and the Closing, the weighted average price per share in such Dilutive Issuances) (except that (i) the exercise price of options, warrants and other similar securities that have been granted or issued, as applicable, prior to the date hereof, and which are exercised following the date hereof and prior to the Closing, shall not be taken into consideration in calculating the price per share for purposes of this clause 1, and (ii) with respect to options, warrants and other similar securities that are granted or issued, as applicable, following the date hereof and prior to closing, the full exercise price (disregarding cashless exercise and similar mechanisms) will be taken into consideration in calculating the price per share for purposes of this clause 1) and (2) the Purchase Price Per Share; or (B) in circumstances not covered in clause (A), the Purchase Price Per Share; (ii) the Seller shall not be obligated to sell to the Purchaser pursuant to this Section 1.6 more than 346,931 Ordinary Shares; and (iii) any additional Ordinary Shares purchased by the Purchaser pursuant to this Section 1.6 shall reduce the number of Call Option Shares and Put Option Shares, respectively.
 
 
- 2 -

 
 
2.
Closing.
 
2.1.           Unless this Agreement is earlier terminated pursuant to Section 7 hereof, the consummation of the sale and purchase of the Purchased Shares and, if applicable, the Related Assets, (the “Closing”) will take place at the offices of Meitar Liquornik Geva Leshem Tal, Law Offices, 16 Abba Hillel Road, Ramat Gan, Israel, fifteen (15) days following the satisfaction or waiver of the closing conditions set forth herein (other than those that by their terms are to be satisfied or waived at the Closing, but subject to the satisfaction or waiver of those conditions), or at such other time, date and location as the Purchaser and Seller shall agree in writing. The date upon which the Closing hereunder actually occurs shall be referred to herein as the “Closing Date”. All actions at the Closing and all transactions occurring at the Closing shall be deemed to take place simultaneously and no transactions shall be deemed to have been completed or any document delivered until all such transactions have been completed and all required documents delivered.
 
2.2.           At the Closing, the Seller shall deliver, or cause to be delivered, to the Purchaser the following documents:
 
2.2.1.                Share transfer deed, duly executed by the Seller, transferring to the Purchaser the Purchased Shares, in the form attached hereto as Exhibit 2.2.1;
 
2.2.2.                Original share certificate(s) representing the Ordinary Shares held by the Seller;
 
2.2.3.                An irrevocable letter of instruction from the Company instructing the transfer agent of the Company's Ordinary Shares to (i) issue new certificates, the first one in the name of the Purchaser, representing the Purchased Shares, and the other one in the name of the Seller, representing the balance of the Ordinary Shares not being sold to the Purchaser hereunder, and (ii) record the transfer pursuant to this Agreement, substantially in the form attached hereto as Exhibit 2.2.3;
 
2.2.4.                A certificate in the form attached hereto as Exhibit 2.2.4 executed by the Seller certifying (i) that the representations and warranties of the Seller hereunder are true and correct as of the date hereof and as of the Closing Date as if made on such date; (ii) that all covenants required by the terms hereof to be performed by the Seller on or prior to the Closing Date have been so performed in all material respects; (iii) the total number of Ordinary Shares issued and outstanding as of immediately prior to the Closing Date, and (iv) a complete and accurate description of any Related Assets;
 
 
- 3 -

 
 
2.2.5.                A letter from Bank Ha Poalim (the “Bank”), in form and substance reasonably satisfactory to the Purchaser, confirming and undertaking, irrevocably, (i) that any and all Encumbrances, rights or interests of the Bank in the Purchased Shares and, if applicable, the Related Assets shall be terminated, released and removed upon payment to the Bank of an amount specified in such letter (which amount shall not exceed the Purchase Price), (ii) that any and all registrations of such Encumbrances in the Registrar of Companies or otherwise shall be removed promptly after such payment; and (iii) as required pursuant to Section 3.8 of the Shareholders Agreement; and
 
2.2.6.                If applicable, instruments evidencing any Related Assets and the transfer and/or assignment of such Related Assets from Seller to the Purchaser, in a form reasonably satisfactory to the Purchaser.
 
2.2.7.                (i) a letter in the form attached hereto as Exhibit 2.2.7(A) signed by Mr. Yossi Shahror appointing, effective as of immediately after the Closing, Mr. Harel Beit On as his alternate director for the period until the next annual shareholders meeting of the Company in which the directors of the Company are elected, (ii) a resignation letter in the form attached hereto as Exhibit 2.2.7(B) pursuant to which Mr. Shahror resigns from the Board of the Company effective as of  the date of delivery of such letter to the Company, which resignation letter will be deposited in escrow in the hands of Purchaser and delivered to the Company in accordance with the terms of the Letter (as defined below), and (iii) a letter from Mr. Shahror to the Purchaser in the form attached hereto as Exhibit 2.2.7(C) (the “Letter”), pursuant to which Mr. Sharor authorizes the Purchaser to deliver the resignation letter referred to above to the Company at such time that the appointment of Mr. Beit On as an alternate director in Mr. Shahror's stead is terminated for any reason.
 
2.3.           At the Closing, the Purchase Price shall be deposited by Purchaser with MLGLB Trust Ltd., as escrow agent (the "Escrow Agent") pursuant to the escrow agreement in the form attached hereto as Exhibit 2.3 and shall be released to the Bank upon receipt of a share certificate representing the Purchased Shares in the name of the Purchaser.
 
2.4.           At the Closing, the Purchaser shall deliver to the Seller a certificate in the form attached hereto as Exhibit 2.4 executed by the Purchaser certifying that: (i) the representations and warranties of the Purchaser hereunder are true and correct as of the date hereof and as of the Closing Date as if made on such date; (ii) all covenants required by the terms hereof to be performed by the Purchaser on or prior to the Closing Date have been so performed in all material respects; and (iii) if applicable, its election to purchase additional Ordinary Shares in accordance with the provisions of Section 1.6.
 
2.5.           If (i) the Rivel Agreement is consummated and (ii) this Agreement is terminated (other than due to the event described in Section 7.1.4.1)7.1.2, then, upon both of such conditions being met, the Seller shall pay the Purchaser, upon termination of this Agreement as aforesaid, an amount in cash of $196,439.
 
3.           Representations and Warranties of Seller. The Seller hereby represents and warrants to the Purchaser as follows:
 
3.1.           Seller has the full corporate power and authority to execute and deliver this Agreement and any agreement, document and instrument provided for or contemplated herein (collectively, the “Transaction Documents”) and to perform the transaction contemplated hereby and thereby. The execution, delivery and performance by the Seller of each of the Transaction Documents has been duly authorized, executed and delivered by the Seller. The persons executing and delivering this Agreement on behalf of the Seller have been duly authorized to do so. The Transaction Documents constitute or will, when executed and delivered by all parties thereto, constitute Seller’s valid and legally binding obligation enforceable against it in accordance with its respective terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.
 
 
- 4 -

 
 
3.2.           The Seller has good and valid title to, and is the sole lawful owner, beneficially and of record, of all of the Purchased Shares (subject to the Encumbrance in favor the Bank, which will be removed as of the Closing). Upon receipt of any Related Assets, the Seller shall have good and valid title to, and shall be the sole lawful owner, beneficially and of record, of all of such Related Assets (subject to an Encumbrance in favor the Bank, which will be removed as of the Closing).  The Seller has sole voting power and sole power to issue instructions with respect to the matters set forth in this Agreement, sole power of disposition and sole power to agree to all of the matters set forth in this Agreement. At the Closing, the Seller shall convey to the Purchaser, and the Purchaser shall acquire, good and marketable title to the Purchased Shares and, if applicable, the Related Assets, free and clear of any and all Encumbrances.  “Encumbrance” (and words of similar import) shall mean any lien, pledge, hypothecation, charge, equities, claims, restrictions, options, proxies, security interest, encumbrance, adverse claim, interference, right of first refusal, preemptive right or restriction, limitation or rights of third parties of any nature (including any restriction or limitation on the voting, transfer, receipt of any income derived from, or on the use of any security or other asset or any restriction or limitation on the possession, exercise or transfer of any other attribute of ownership of a security). The Seller has neither sold, pledged, Encumbered or otherwise transferred, nor undertook or promised to do so (whether by operation of law or otherwise) the Purchased Shares or any interests therein to any person, other than pursuant to (i) a pledge in favor of the Bank, which shall be removed immediately prior to Closing and (ii) this Agreement. If the Seller receives any Related Assets, it shall neither sell, pledge, Encumber or otherwise transfer, nor undertake or promise to do so (whether by operation of law or otherwise) any of the Related Assets or any interests therein to any person, other than pursuant to (i) a pledge in favor of the Bank, which shall be removed immediately prior to Closing and (ii) this Agreement.
 
3.3.           The Purchased Shares constitute as of the date hereof 13% of the Company’s issued and outstanding share capital. The certificate delivered pursuant to Section 2.2.4 shall set forth a complete and accurate description of the Related Assets as of the Closing. The number of Ordinary Shares set forth in the first recital to this Agreement constitute all of the shares or other securities over which any voting or dispositive power is held by the Seller and Seller does not own, beneficially or otherwise, nor control, directly or indirectly, any other share capital of, or other securities, equity or ownership interest in the Company (including, without limitation, (i) any outstanding options, warrants, purchase rights, subscription rights, conversion rights, exchange rights or other similar contracts relating to securities of the Company, or (ii) outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to securities of the Company). Neither the Purchased Shares nor any other Ordinary Shares set forth in the first recital to this Agreement are subject to any shareholders agreement, voting agreements, proxies, trusts or other agreement or understandings relating to any attribute thereof, including the voting or disposition thereof or any other Encumbrance, except as set forth in this Agreement and the pledge in favor of Bank Ha Poalim. Other than (i) as set forth in Section 1.3 and (ii) pursuant to the pledge in favor of Bank Ha Poalim, there are no transfer restrictions or right of first refusal, right of first offer, tag along or other similar rights applicable to the Purchased Shares. There are no agreements, instruments or documents between the Company or its affiliates, on the one hand, and the Seller or its affiliate, on the other hand, relating to any rights in or to the Purchased Shares or to any other matter.
 
 
- 5 -

 
 
3.4.           The execution and delivery by the Seller of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, require Seller to obtain or deliver any notice, consent, waiver, approval, order or authorization or permit of, or registration, declaration or filing with, or notification to, any court, administrative agency, commission, governmental or regulatory authority or any other person, other than (i) as set forth in Section 1.3., (ii) the approvals set forth in Schedule 5.1.3, (iii) release of the pledge from Bank Ha Poalim as referred to in Section 2.2.5 and (iv) disclosure, as required under the Israeli Securities Law of 1968.
 
3.5.           Except as set forth in Section 1.3 of this Agreement, the execution and delivery by the Seller of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, conflict with, or result in any violation of, or default under (with or without notice or lapse of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation under the Articles of Association of the Company, the Articles of Association or other equivalent organizational or governing documents of the Seller, any agreement, law, rule, regulation, order, judgment or decree applicable to the Seller or that apply to the Purchased Shares and, if applicable, the Related Assets or by which the Purchased Shares and, if applicable, the Related Assets are bound, or, to the knowledge of the Seller, any agreement, law, rule, regulation, order, judgment or decree applicable to the Company or to which its assets are subject.
 
3.6.           There is no suit, action, proceeding, claim or investigation, decrees, orders, judgments or legal proceeding of any nature, pending, or, to Seller’s knowledge, threatened against the Seller or the Purchased Shares and, if applicable, the Related Assets, that seeks to prevent Seller from executing, delivering or performing the Transaction Documents and the transactions contemplated hereby and thereby, or that apply to the Purchased Shares and, if applicable, the Related Assets or by which they are bound.
 
3.7.           No agent, broker, finder, investment banker, person or firm acting in a similar capacity on Seller’s behalf or under the Seller’s authority is, nor will it be, entitled to any brokerage or finder’s fee or any other commission or similar fee, directly or indirectly, in connection with the origin, negotiation or execution of the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby, which would be required to be paid by the Purchaser or the Company.
 
3.8.           Seller agrees to sell the Purchased Shares and, if applicable, the Related Assets to the Purchaser at the Purchase Price provided for herein notwithstanding any possible knowledge differential between the parties, any potential or prospects each party may view for the Company, any potential future role of Purchaser in the corporate governance of the Company, and any potential future appreciation, benefit or privileges relating to the Ordinary Shares, and accordingly Seller hereby irrevocably waives any right, claim or demand that may arise as a result thereof against the Purchaser and its affiliates and representatives.
 
3.9.           The Seller does not currently hold, directly or indirectly, any interest in, nor does the Seller currently have any right with respect to, any asset, nor does Seller expect to have prior to Closing any other right in any asset, in each case which is reasonably expected to result in the imposition of an Antitrust Restraint with respect to the transactions contemplated hereunder.
 
4.           Representations and Warranties of the Purchaser.  The Purchaser hereby represents and warrants to the Seller as follows:
 
4.1.           It is duly formed and validly existing under the laws of its jurisdiction of formation.
 
 
- 6 -

 
 
4.2.           It has the requisite power and authority to enter into the Transaction Documents to which it is a party and to consummate the transactions contemplated hereby and thereby. The execution and delivery of each of the Transaction Documents to which it is a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Purchaser. The persons executing and delivering this Agreement on its behalf have been duly authorized to do so. The Transaction Documents to which it is a party have been duly executed and delivered by it and, assuming the due authorization, execution and delivery by the other parties hereto, constitute its valid and binding obligations, enforceable against it in accordance with their terms, except as such enforceability may be limited by principles of public policy and subject to the laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies.
 
4.3.           The execution and delivery by it of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, require such Purchaser to obtain or deliver any notice, consent, waiver, approval, order or authorization or permit of, or registration, declaration or filing with, or notification to any court, administrative agency, commission, governmental or regulatory authority or any other person, that has not been, or will not be, obtained by the Closing and other than the approvals set forth in Schedule 5.1.3.
 
4.4.           The execution and delivery of the Transaction Documents do not, and the consummation of the transactions contemplated hereby and thereby will not, conflict with, or result in any violation of or default under (with or without notice or lapse of time, or both) or give rise to a right of termination, cancellation, modification or acceleration of any obligation or loss of any benefit under any provision of the Purchaser’s formation documents; or any law, rule, regulation, order, judgment or decree applicable to it.
 
4.5.           There is no suit, action, proceeding, claim or investigation, decrees, orders, judgments or legal proceeding of any nature, pending, or, to such Purchaser’s knowledge, threatened against it, that seeks to prevent it from executing, delivering or performing the Transaction Documents and the transactions contemplated hereby and thereby.
 
4.6.           No agent, broker, finder, investment banker, person or firm acting in a similar capacity on such Purchaser’s behalf or under its authority is, nor will it be, entitled to any brokerage or finder’s fee or any other commission or similar fee, directly or indirectly, in connection with the origin, negotiation or execution of the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby, which would be required to be paid by any of the Seller or the Company.
 
4.7.         Purchaser acknowledges and understands that the Purchased Shares have not been, and, if applicable, the Related Assets shall not have been, and none of them will be, as of the Closing, registered under the U.S. Securities Act of 1933 (the "Securities Act"), and that Purchaser may not offer, resell or otherwise transfer the Purchased Shares and, if applicable, the Related Assets except pursuant to (i) an effective registration statement under the Securities Act covering such offer, sale or transfer and provided that such offer, sale or transfer is made in accordance with such registration statement, or (ii) an available exemption from registration under the Securities Act. The Purchaser acknowledges and agrees that the Company may require that each certificate representing Purchased Shares and, if applicable, the Related Assets be imprinted with a legend listing such transfer restrictions. The Purchaser has requested that Seller not disclose to it any material, non-public information concerning the Company ("Excluded Information") and Seller has complied with the Purchaser's request. As a consequence of such non-disclosure of Excluded Information, there may exist a disparity of information between Purchaser and Seller with respect to the Company.  As a condition to Seller’s agreement to sell the Purchased Shares and, if applicable, the Related Assets hereunder, Purchaser expressly release Seller from any and all damages as well as loss of profit or potential profit that may be incurred by the Purchaser as a result of the Purchaser’s decision to purchase the Purchased Shares and, if applicable, the Related Assets without having access to the Excluded Information, provided that the Excluded Information shall not affect the truth or accuracy of Seller’s representations and warranties made herein.
 
 
- 7 -

 
 
4.8.         The Purchaser does not currently hold, directly or indirectly, any interest in, nor does the Seller currently have any right with respect to, any asset nor does Purchaser expect to have prior to Closing any other right in any asset, in each case which is reasonably expected to result in the imposition of an Antitrust Restraint with respect to the transactions contemplated hereunder.
 
5.
Conditions to Closing.
 
5.1.           Conditions to Closing of each Party. The respective obligations of the Seller and the Purchaser to effect the Closing are subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any of which may be waived, in writing, by mutual written instrument of the Seller and the Purchaser:
 
5.1.1.                No Order. No court or other governmental authority shall have enacted, issued, promulgated, enforced or entered any statute, rule, regulation, executive order, decree, judgment, injunction or other order (whether temporary, preliminary or permanent) which is in effect and which has the effect of preventing, enjoining, restraining, prohibiting or otherwise making this Agreement or the transactions contemplated hereby illegal.
 
5.1.2.                Transfer Restrictions Period.  The 14–day period from the date of receiving the Sale Notice by each of the parties entitled thereto pursuant to Section 2 of that certain Tag Along Agreement shall have elapsed.
 
5.1.3.                Regulatory Consents.  The approvals set forth in Schedule 5.1.3 shall have been obtained, without conditions.
 
5.2.           Conditions to Closing of the Purchaser. The obligations of the Purchaser to effect the Closing are subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions, any of which may be waived, in writing, by the Purchaser:
 
5.2.1.                Representations, Warranties and Covenants. (i) The representations and warranties of the Seller in this Agreement shall have been true and correct on the date hereof and as of the Closing Date with the same effect as if made at and as of the Closing Date, and (ii) the Seller shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by the Seller at or prior to the Closing Date.
 
5.2.2.                Receipt of Closing Deliveries. Each of the agreements, instruments and other documents required to be delivered by the Seller under Section 2.2 shall have been received by Purchaser.
 
5.2.3.                No Injunctions or Restraints. No permanent restraining orders, temporary restraining order (that was not removed prior to Closing) or permanent injunction or other order issued by any administrative agency, commission, regulatory or governmental authority which has or could have the effect of limiting or restricting the Purchaser’s ownership or voting of the Purchased Shares and, if applicable, the Related Assets shall be in effect, nor shall there be pending or threatened any suit, action or proceeding seeking the foregoing or any other Antitrust Restraint (as defined below).
 
 
- 8 -

 
 
5.2.4.                No Company Material Adverse Effect.  No change, fact, circumstance, condition, event or effect shall have occurred prior to the Closing, that individually or when taken together with such other changes, facts, circumstances, conditions, events or effects shall have or would reasonably be expected to have a long term material and adverse effect on the business, operations, results of operations, assets, liabilities or condition (financial or otherwise) of the Company and its subsidiaries, provided that such material and adverse effect shall have existed as of the date on which all conditions to Closing (other than the absence of such material and adverse effect) shall have been met; provided that, in determining whether a material adverse effect has occurred, there shall be excluded any effect resulting from (i) changes in conditions affecting generally the industry in which the Company operates or the economic, capital or securities markets, financial or political conditions worldwide, (ii) any changes in political conditions, natural disasters and earthquakes, acts of war, armed hostilities, sabotage or terrorism, or escalation or material worsening of any of the foregoing, (iii) mandatory changes in accounting standards or any authoritative interpretation thereof, (iv) changes in exchange rates, and (v) any decline in the market price or decrease or increase in the trading volume of the Ordinary Shares after the date of this Agreement, in and as of itself; provided that with respect to clauses (i) through (iv) above, such changes do not have a disproportionate impact on the Company compared to similarly situated companies.
 
5.2.5.                Rivel Closing. The Rivel Closing shall have been consummated.
 
5.2.6.                Shareholders Agreement Terminated.  The expiration of 30 days from the date of the Rivel Closing, and at the end of such date that certain Shareholders Agreement between Rivel and Del-Ta dated October 5, 2006 shall have terminated.
 
5.3.           Conditions to Closing of the Seller. The obligations of the Seller to effect the Closing are subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions, any of which may be waived, in writing, by Seller:
 
5.3.1.                Representations and Warranties. (i) The representations and warranties of the Purchaser in this Agreement shall have been true and correct as of the date hereof and on and as of the Closing Date with the same effect as if made at and as of the Closing Date, and (ii) the Purchaser shall have performed and complied in all material respects with all covenants and obligations under this Agreement required to be performed and complied with by the Purchaser at or prior to the Closing Date.
 
5.3.2.                Receipt of Closing Delivery. The certificate required to be delivered by the Purchaser to the Seller under Section 2.3 shall have been received by Seller.
 
6.
Covenants.
 
6.1.           Additional Documents and Further Assurance. Subject to the terms and conditions of this Agreement and any applicable law, each party hereto, at the reasonable request of another party hereto, shall execute and deliver, or cause to be executed and delivered, such other documents and instruments and do and perform such other actions as may be necessary or desirable for effecting completely the consummation of the Transaction Agreements and the transactions contemplated hereby and thereby.
 
6.2.           Call Option.
 
6.2.1.                The Seller hereby grants Purchaser, subject to the Closing, a call option to purchase from Seller an aggregate of 346,931 Ordinary Shares, as may be reduced pursuant to Section 1.6 above (the "Call Option" and the "Call Option Shares", respectively) and, if applicable, the Call Option Related Assets (as defined below) in consideration for a price per share equal to US$10.00 (reduced by the gross amount per share of all dividend or other distributions effected by the Company following the date hereof and through the date of the Call Option Closing) and on the terms set forth in this Section 6.2. For purposes of this Section 6.2, “Call Option Related Assets” shall mean all rights, assets, properties or securities of any kind distributed, issued or granted in respect of, in exchange or in addition to, the Call Option Shares, following the date hereof and through the date Call Option Closing, and any right or entitlement to receive the same, but excluding distributions to the extent deducted from the purchase price thereof as set forth above.  Whether or not specifically indicated, any reference to the Call Option Shares shall include, if applicable, the Call Option Related Assets.
 
 
- 9 -

 
 
6.2.2.                If the Purchaser wishes to exercise the Call Option, it shall notify the Seller in writing, at one time or from time to time during the period commencing on September 30, 2013 and ending at 19:00 Israel time on September 30, 2014 (the “Call Option Exercise Period”), indicating in each such notification the number of Call Option Shares it wishes to purchase up to the Call Option Shares. As promptly as practicable thereafter, the Seller shall deliver to the Purchaser a written notice describing the Call Option Related Assets.
 
6.2.3.                The closing of the purchase of the Call Option Shares indicated in the Purchaser's exercise notice and, if applicable, the Call Option Related Assets (the "Call Option Closing") shall take place on the later of (i) the 10th business day following the delivery of the Purchaser's exercise notice, or (ii) the third business day after such time as the applicable regulatory approvals and requirements (if any) with respect to the purchase of such Call Option Shares and, if applicable, the Call Option Related Assets shall have been obtained or satisfied, provided that by such date the 14-day period referred to in Section 1.3 shall have elapsed (for as long as the Tag Along Agreement is in effect), at such place in Israel as the parties shall agree. The provisions of this Agreement shall apply, mutatis mutandis, to the purchase of Call Option Shares and, if applicable, the Call Option Related Assets (including, without limitation, Sections 1.4, 2.2, 2.3, 2.4, 3, 4, 5 (and in such case Schedule 5.1.3 shall include the required regulatory approvals, and other than 5.2.4), 6.4 and 7.1.2 (with reference to the date of exercise of the Call Option), and the Call Option Shares and, if applicable, the Call Option Related Assets so purchased shall be deemed as Purchased Shares for all purposes under this Agreement from the Call Option Closing.
 
6.2.4.                Notwithstanding the Call Option Exercise Period, the Call Option shall expire upon the earlier of the following: (i) the earlier of: (a) such time as the Purchaser purchases from the Seller Ordinary Shares pursuant to Section 2.5 of the Shareholders Agreement in an amount equal to or in excess of the number of the Call Option Shares; (b) such time as the Purchaser notifies the Seller in writing that it declines the offer pursuant to Section 2.5 of the Shareholders Agreement; or (c) the expiration of the applicable period for accepting the offer pursuant to Section 2.5 of the Shareholders Agreement; (ii) the date of consummation of a transaction for the sale of all of the Company’s issued share capital (however structured); or (iii) the date of consummation of a Transfer of all Ordinary Shares held by the Seller in accordance with Section 6 (Bring Along) of the Shareholders Agreement and as defined therein.
 
6.2.5.                The Purchaser shall be entitled to apportion or assign the Call Option, in whole or in part, to its affiliates and Permitted Transferees (as defined in the Shareholders Agreement) or to designate any third party purchaser as notified to the Seller.
 
6.2.6.                Notwithstanding anything to the contrary in the Shareholders Agreement, unless the Call Option has expired prior to such date as set forth in Section 6.2.4 above, then the Seller shall be subject to the provisions of Section 2.1 of the Shareholders Agreement with respect to the Call Option Shares and, if applicable, the Call Option Related Assets until the later of (i) the expiration of the Call Option Exercise Period; or (ii) the date of the Call Option Closing, if an exercise notice was delivered during the Call Option Exercise Period.
 
 
- 10 -

 
 
6.3.           Put Option.
 
6.3.1.                The Purchaser hereby grants Seller, subject to the Closing, a put option to sell to the Purchaser such number of Ordinary Shares up to the maximum number of the Call Option Shares (the "Put Option" and the "Put Option Shares", respectively) and, if applicable, the Call Option Related Assets (as defined in Section 6.2, but with reference to the Put Option (the "Put Option Related Assets")) in consideration for a price per share equal to US$8.00 (reduced by the gross amount per share of all dividend or other distributions effected by the Company following the date hereof and through the date of consummation of Put Option), after deduction of the applicable tax withholding, and on the terms set forth in this Section 6.3.
 
6.3.2.                If the Seller wishes to exercise the Put Option, it shall notify the Purchaser, in writing, at one time or from time to time during the period commencing on September 30, 2013 and ending at 19:00 Israel time on March 31, 2014 (the “Put Option Exercise Period”) indicating the number of Put Option Shares it wishes to sell. As promptly as practicable thereafter, the Seller shall deliver to the Purchaser a written notice describing the Put Option Related Assets.
 
6.3.3.                The closing of the purchase of the Put Option Shares indicated in the Seller's exercise notice and, if applicable, the Put Option Related Assets shall take place on the later of (i) the 30th business day following the delivery of the Seller's exercise notice, or (ii) the third business day after such time as the applicable regulatory approvals and requirements (if any) with respect to the purchase of such Put Option Shares and, if applicable, the Put Option Related Assets shall have been obtained or satisfied, at such place in Israel as the parties shall agree. The parties shall enter into an agreement for the sale and purchase of such Put Option Shares and, if applicable, the Put Option Related Assets on the terms set forth in this Section 6.3 and otherwise as reasonably agreed.
 
6.3.4.                Notwithstanding the Put Option Exercise Period, the Put Option shall expire upon the earlier of the following: (i) a transaction for the sale of all of the Company’s issued share capital (however structured); or (ii) a transfer of all Ordinary Shares held by the Purchaser.
 
6.3.5.                The Purchaser shall be entitled to apportion or assign the Put Option, in whole or in part, to its affiliates and Permitted Transferees (as defined in the Shareholders Agreement) or to designate any third party purchaser as notified to the Seller.
 
6.4.           Filings; Notices and Approvals.
 
6.4.1.                As promptly as practicable after the date of this Agreement, the parties shall use their commercially reasonable efforts to deliver and file each notice, report or other document, or obtain the consent or approval, required to be delivered, or filed by such party with, or obtained from any governmental or regulatory authority or any third party, with respect to this Agreement and the other agreements and the transactions entered into on the date hereof or contemplated hereby. Each of the Seller and the Purchaser shall cause all documents that it is responsible for filing with or delivering to any governmental or regulatory authority or any third party under this Section 6.2.1 to comply as to form and substance in all material respects with the applicable legal requirements and contractual obligations and shall keep each other apprised of the status of any communications with, and any inquiries or requests for additional information from, any governmental or regulatory authority or any third party and shall comply promptly with any such inquiry or request.
 
 
- 11 -

 
 
6.4.2.                Notwithstanding anything in this Agreement to the contrary: (i) neither Purchaser nor Seller shall have any obligation to litigate or contest any administrative or judicial action or proceeding, any decree, judgment, injunction or other order, whether temporary, preliminary or permanent, or any condition or term for the approval or consent of any governmental or regulatory authority or any third party to the transactions contemplated under this Agreement or the other agreements among the parties referenced herein; and (ii) neither Purchaser nor Seller shall be under any obligation to make proposals, execute or carry out agreements or submit to orders providing for (A) the sale, license or other disposition or holding separate (through the establishment of a trust or otherwise) of any assets or categories of assets of Purchaser or Seller or any of their respective affiliates or the Company or its affiliates, (B) the imposition of any limitation or regulation on the ability of Purchaser or Seller or any of their respective affiliates to freely conduct their business or own such assets, or (C) the holding separate of the shares of the Company or any limitation or regulation on the ability of Purchaser or Seller or any of their respective affiliates to exercise full rights of ownership of the shares of the Company (any of the foregoing, an “Antitrust Restraint”). Each party undertakes, until the earlier of the Closing or the termination of this Agreement in accordance with Section 7 hereof, not to acquire, directly or indirectly, any interest in, nor to hold any right with respect to, any asset, which ownership of or any other right in any asset would be reasonably expected to result in the imposition of an Antitrust Restraint with respect to the transactions contemplated hereunder.
 
7.
Termination.
 
7.1.           This Agreement may be terminated at or prior to the Closing, only as follows:
 
7.1.1.                By written consent of the parties hereto;
 
7.1.2.                By written notice of the Purchaser or the Seller, if the Closing Date shall not have occurred by the expiration of 180 days after the date hereof (the “Termination Date”) (which date may be extended by the Purchaser or the Seller by an additional 45 days if the Closing has not occurred due to the condition in Section 5.1.3 not being satisfied); provided, however, that the right to terminate this Agreement under this Section 7.1.2 shall not be available to any party whose action or failure to act has been a principal cause of or resulted in the failure of the Closing to occur on or before such Termination Date;
 
7.1.3.                By written notice of the Purchaser to Seller, referring to the relevant clause of this subsection if:
 
   7.1.3.1.                There has been a breach of any representation, warranty, covenant or agreement of the Seller contained in this Agreement such that if Closing were to occur on the date of such termination such breach would result in the failure of any of the conditions set forth in Sections 5.15 (as it applies to Seller) hereof to be satisfied and such breach has not been cured within ten (10) days after written notice thereof to the Seller; provided, however, that no cure period shall be required for a breach which by its nature cannot be cured.
 
   7.1.3.2.                There shall be statute, rule, regulation or order enacted, promulgated or issued or applicable to the transactions contemplated hereby by any governmental authority, which has or could have the effect of limiting or restricting the Purchaser’s ownership or voting of the Purchased Shares and, if applicable, the Related Assets or imposing any Antitrust Restraint on the Purchaser or the Company.
 
   7.1.3.3.                Any of the conditions in Sections 5.2.3, 5.2.4, 5.2.5 or 5.2.6 is not or is reasonably expected not to be satisfied by the Termination Date.
 
 
- 12 -

 
 
7.1.4.                By written notice of the Seller to Purchaser, referring to the relevant clause of this subsection if:
 
   7.1.4.1.                There has been a breach of any representation, warranty, covenant or agreement of the Purchaser contained in this Agreement such that if Closing were to occur on the date of such termination such breach would result in the failure of any of the conditions set forth in Sections 5 (as it applies to Purchaser) hereof to be satisfied and such breach has not been cured within ten (10) days after written notice thereof to the Seller; provided, however, that no cure period shall be required for a breach which by its nature cannot be cured.
 
   7.1.4.2.                There shall be any statute, rule, regulation, executive order, decree, judgment, injunction or other order enacted, issued, promulgated, enforced, entered or deemed applicable by any governmental authority which has or could have the effect of limiting or restricting the Seller’s right to sell the Purchased Shares and, if applicable, the Related Assets or imposing any Antitrust Restraint on the Seller or the Company.
 
7.2.           Effect of Termination. In the event of termination of this Agreement as provided in Section 7.1 hereof, this Agreement shall forthwith become void and there shall be no liability or obligation on the part of the Purchaser or the Seller, or their respective employees, agents or shareholders, if applicable, except that the provisions of Section 2.5, 8 and this Section 7.2 shall remain in full force and effect and survive any termination of this Agreement pursuant to the terms of this Section 7, and except to the extent that such termination results from a material breach by the other party of any representation, warranty or covenant set forth in this Agreement.
 
8.
General.
 
8.1.           Expenses. Each party shall bear its own costs and expenses incurred with respect to the negotiation, execution, delivery and performance of this Agreement.
 
8.2.           Entire Agreement. This Agreement and the exhibits and schedules attached hereto, and the documents and instruments and other agreements referenced herein, constitute the full and entire understanding and agreement between the parties with respect to the subject matters hereof and thereof, and supersede any prior understandings, agreements, or representations by or among the parties, written or oral, to the extent they relate in any way to the subject matter hereof.
 
8.3.           Amendment. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the parties hereto. Any amendment or waiver effected in accordance with this Section shall be binding upon all parties of this Agreement and their respective successors and assignees.
 
8.4.           Press Releases.  No party shall issue any statement or communication to any third party (other than their respective agents, current or future partners, affiliates and representatives that are bound by confidentiality restrictions) regarding this Agreement, its existence and content, or the transactions contemplated hereby, including, if applicable, the termination of this Agreement and the reasons therefor, without the consent of the other parties hereto, except as required to comply with applicable legal requirements and the rules of any stock exchange.
 
8.5.           Remedies.  The parties hereby acknowledge that monetary damages may not be a sufficient or adequate remedy for any breach or violation of any of their respective obligations under Section 6 and that, in addition to any other remedy which may be available to any of them hereunder or in law or equity, and without any wavier or limitation with respect thereto, the non-breaching/violating party shall be entitled to injunctive and other equitable relief, including specific performance, with respect to any such breach or violation and to enforce specifically the terms and provisions hereof, in any court of competent jurisdiction. Any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy.
 
 
- 13 -

 
 
8.6.           Assignment. Neither this Agreement, nor any rights, interests or obligations under this Agreement may be assigned or transferred, in whole or in part, by operation of law or otherwise by any party hereto, without the prior consent in writing of the other party hereto, and any such assignment without such prior written consent shall be null and void, except that this Agreement or any of the rights, interests or obligations under this Agreement may be assigned by the Purchaser upon notice to the other party, to any of the Viola Partners or Viola Credit funds and their respective affiliates or to a lender providing financing for the purchase of the Purchased Shares and, if applicable, the Related Assets hereunder, or in accordance with Section 6.2. Subject to the foregoing, this Agreement shall inure to the benefit of, and be binding upon, and be enforceable by, the parties hereto and their respective successors, assigns, heirs, executors, and administrators.
 
8.7.           Viola Designation. The entity executing this Agreement as the Purchaser (“Executing Party”) is signing this Agreement, as well as any instruments, certificates, exhibits and schedules attached hereto or contemplated hereby, on behalf of itself or as a nominee or trustee of an affiliate thereof, as shall be indicted in writing to the Seller prior to the Closing.  In case this Agreement is signed by the Executing Party as a nominee or trustee, then any reference to the “Purchaser” hereunder shall refer to such affiliate, as if an original party hereof, and the Executing Party shall have no further rights or obligations hereunder.
 
8.8.           Governing Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Israel, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof. Each of the parties hereto irrevocably consents to the exclusive jurisdiction and venue of any competent court located in Tel-Aviv-Jaffa, Israel in connection with any matter based upon or arising out of this Agreement or the matters contemplated herein, agrees that process may be served upon them in any manner authorized by the laws of the State of Israel for such persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction and such process.
 
8.9.           Definitions. When used herein: the words “include,” “includes” and “including” shall be deemed in each case to be followed by the words “without limitation”; the words “herein,” “hereof,” “hereto” and “hereunder” and words of similar import, shall refer to this Agreement as a whole and not to any particular provision of this Agreement; the word “person(s)” shall include an individual, corporation, partnership, association, trust, enterprise or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof; the phrase “beneficial ownership” of any securities or “own” (and phrases of similar import) shall mean beneficial ownership for purposes of Rule 13d-3 under the US Securities Exchange Act of 1934 (the "Exchange Act") (and for the purposes of Rule 13d-3(d)(1)(i) thereunder, as if the right to acquire beneficial ownership of such security would have been within 60 days); the word “affiliate(s)” (and words of similar import) shall mean as set forth in Rule 405 promulgated under the Securities Act; and the word “group” shall mean any group of persons acting together in the manner described in Rule 13d-5(b)(1) under the Exchange Act.  Unless the context otherwise requires, words denoting the singular number only shall include the plural and vice versa.  "Business Day" (whether or not used as a capitalized term) shall mean each day that is not a Friday or Saturday, or on which banking institutions located in Tel Aviv, Israel are authorized or obligated by law or order to close.
 
 
- 14 -

 
 
8.10.           Interpretation. The headings in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. The recitals, exhibits and schedules form part of this Agreement and shall have the same force and effect as if expressly set out in the body of this Agreement, and any reference to this Agreement shall include the exhibits and schedules hereto. Each of the parties acknowledges that it had assessed the risk, uncertainties and benefits of the transactions contemplated by this Agreement and each Transaction Document to which it is a party, and that it was represented by legal counsel in the negotiation, execution and delivery of the Transaction Documents. Accordingly, and based on the foregoing facts, among other factors, each party acknowledges and agrees that, for purposes of interpreting this Agreement or any other Transaction Document, no party has had any preference in the design of the provisions of this Agreement (within the meaning of Section 25(b1) of the Contracts Law (General Part), 1973 (as amended).
 
8.11.           Severability. If any provision of this Agreement or the application thereof becomes or is declared by a court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. In addition, if any particular provision contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.
 
8.12.           Notices. All notices and other communications hereunder shall be in writing and shall be shall be emailed, faxed or mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger, addressed to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
 
 
8.12.1.
if to the Purchaser, to:
 
Viola Private Equity
Ackerstein Towers, Building D
12 Abba Eban Ave.
Hertzliya Pituach Israel
Attention:                 Harel Beit-On
Telephone No.:        (972)-(9)-9720433
Facsimile No.:           (972)(9)-9594952
Email:                        harelb@violape.com

with a mandatory copy to (which shall not constitute notice):

Meitar Liquornik Geva Leshem Tal
16 Abba Hillel Road Ramat Gan 52506, Israel
Attention:                Dan Shamgar, Advocate
                                 Shira Azran, Advocate
Telephone No.:        (972)-(3)-610-3100
Facsimile No.:           (972)-(3)-6103-111
Email:                       dshamgar@meitar.com
                                  sazran@meitar.com
 
 
- 15 -

 
 
 
8.12.2.
if to the Seller, to:
 
154 Menahem Begin Rd., Tel-Aviv, Israel
Attention: CFO
Telephone No.: (972)-(3)-6083444
Facsimile No.:   (972)-(3)-6083434
Email: Shahror@kardan.com

with a mandatory copy to (which shall not constitute notice):

Meitar Liquornik Geva Leshem Tal
16 Abba Hillel Road Ramat Gan 52506, Israel
Attention:                Mike Rimon, Advocate
Telephone No.:       (972)-(3)-610-3100
Facsimile No.:          (972)-(3)-610-3687
Email:                        mrimon@meitar.com
 
Any notice sent in accordance with this Section 8.12 shall be effective (i) if mailed, three (3) business days after mailing, (ii) if sent by messenger, upon delivery, and (iii) if sent via email or facsimile, upon transmission and electronic confirmation of delivery (with respect to facsimile only) or (if transmitted and received on a non-business day) on the first business day following transmission and electronic confirmation of delivery (with respect to facsimile only); provided, however, that any notice of change of address shall only be valid upon receipt.
 
8.13.           Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and enforceable against the parties actually executing such counterpart, and all of which together shall be considered one and the same agreement, it being understood that all parties need not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile transmission or by electronic delivery in .pdf format or the like shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original.
 
- Signature Pages Follow -
 
 
- 16 -

 
 
IN WITNESS WHEREOF, the parties have caused this Share Purchase Agreement to be duly executed as of the date first written above.
 
 
Viola P.E. GP Ltd.
 
By: /s/ Jonathan Kolber
Name: Jonathan Kolber
Title: Authorized Signatory
 
By: /s/ Harel Beit-On
Name: Harel Beit-On
Title: Authorized Signatory
 
 
Kardan Communications Ltd.
 
By: /s/ Amit Ben-Yehuda
Name: Amit Ben-Yehuda
Title: Authorized Signatory
 
By: /s/ Asher Elmoznino
Name: Asher Elmoznino
Title: Authorized Signatory

- 17 -


EX-5 5 exhibit_5.htm EXHIBIT 5 exhibit_5.htm


Exhibit 5

JOINT FILING AGREEMENT

         The undersigned parties hereby agree that this Schedule 13D filed herewith relating to the ordinary shares, par value NIS 0.01 per share, of RRsat Global Communications Network Ltd., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) on behalf of each such person.

Date: May 17, 2013
 
  Viola A.V. RRsat, Limited Partnership

By:  Viola P.E. GP Ltd.
Its general partner

By: /s/ Harel Beit-On
Name: Harel Beit-On

By: /s/ Avi Zeevi
Name: Avi Zeevi
 
Viola P.E. GP Ltd.
By: /s/ Harel Beit-On
Name: Harel Beit-On

By: /s/ Avi Zeevi
Name: Avi Zeevi

 
/s/ Shlomo Dovrat
Shlomo Dovrat

/s/ Harel Beit-On
Harel Beit-On

/s/ Avi Zeevi
Avi Zeevi